Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CR2,Complement receptor type 2,Lifestyle factors,X1050.Time spend outdoors in summer,49055,-0.0594986824066988,0.0232800000661161,-0.105127482536286,-0.0138698822771112,0.010600662581652
CR2,Complement receptor type 2,Lifestyle factors,X1060.Time spent outdoors in winter,45307,-0.0357475007188187,0.02666746904634,-0.088015740049645,0.0165207386120077,0.180099986634293
CR2,Complement receptor type 2,Physical activities,X1070.Time spent watching television (TV),50226,0.021345555901007,0.0230399411999969,-0.0238127288509869,0.0665038406530009,0.354216087490351
CR2,Complement receptor type 2,Physical activities,X1080.Time spent using computer,45220,-0.00983864393377252,0.0248159082805427,-0.0584778241636363,0.0388005362960913,0.691765839234562
CR2,Complement receptor type 2,Physical activities,X1090.Time spent driving,44085,-0.0551161468156816,0.0262141539002922,-0.106495888460254,-0.00373640517110897,0.0355188626646178
CR2,Complement receptor type 2,Lifestyle factors,X1160.Sleep duration,52029,0.0143377405648048,0.0216234827822189,-0.0280442856883442,0.0567197668179538,0.507295359541917
CR2,Complement receptor type 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34541,0.00708441320358919,0.0158448803307338,-0.023971552244649,0.0381403786518274,0.654804306010179
CR2,Complement receptor type 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34541,0.0169691659628066,0.0155896053191168,-0.0135864604626624,0.0475247923882756,0.276402376077047
CR2,Complement receptor type 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34541,0.0151469501083326,0.0182992068668119,-0.0207194953506187,0.0510133955672839,0.407837349314805
CR2,Complement receptor type 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34541,-0.00204396086353259,0.0189895395128476,-0.039263458308714,0.0351755365816488,0.914286344172305
CR2,Complement receptor type 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34541,-0.00785519762418467,0.0195289118011033,-0.0461318647543471,0.0304214695059777,0.687519670762535
CR2,Complement receptor type 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34541,0.0397063072484409,0.0372761086639211,-0.0333548657328446,0.112767480229726,0.286811984394559
CR2,Complement receptor type 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34541,0.0182080348889047,0.0384806458971491,-0.0572140310695076,0.093630100847317,0.636098831112219
CR2,Complement receptor type 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34541,-0.00483399402626053,0.0275104075232716,-0.0587543927718729,0.0490864047193519,0.860521102300571
CR2,Complement receptor type 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34541,-0.0144628926846683,0.0202249118338241,-0.0541037198789636,0.0251779345096269,0.474561104897998
CR2,Complement receptor type 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34541,0.00765724949896251,0.014174673899899,-0.0201251113448394,0.0354396103427645,0.589065965440841
CR2,Complement receptor type 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34541,0.0284316231281316,0.0201194952131269,-0.0110025874895971,0.0678658337458603,0.157644293465588
CR2,Complement receptor type 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34541,0.00359139914860728,0.0115099583844209,-0.0189681192848577,0.0261509175820723,0.75502732506828
CR2,Complement receptor type 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34541,0.00823570325471729,0.0147593128381365,-0.0206925499080302,0.0371639564174648,0.576855769799602
CR2,Complement receptor type 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34541,-0.0105111331729053,0.0224139975403858,-0.0544425683520616,0.0334203020062509,0.639112107858576
CR2,Complement receptor type 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34541,0.0190555981743178,0.0211941290572826,-0.022484894777956,0.0605960911265916,0.368620753572468
CR2,Complement receptor type 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34541,-0.00724430146478208,0.0260060252609112,-0.0582161109761681,0.0437275080466039,0.780586044560624
CR2,Complement receptor type 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34541,-0.0222630894904185,0.0244672458951723,-0.0702188914449563,0.0256927124641192,0.362888400094696
CR2,Complement receptor type 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34541,0.0174627720060677,0.0165088412937793,-0.0148945569297398,0.0498201009418751,0.290178297679367
CR2,Complement receptor type 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34541,-0.000510820595048173,0.0156603428815343,-0.0312050926428554,0.030183451452759,0.973979237844011
CR2,Complement receptor type 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34541,0.0193227248609384,0.0193265679317895,-0.018557348285369,0.0572027980072458,0.31742939803594
CR2,Complement receptor type 2,Health and medical history,X120040.Fatigue severity over the past week,34549,0.0652977368167765,0.0368552917534355,-0.00693863501995708,0.13753410865351,0.0764673780185135
CR2,Complement receptor type 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34551,0.0571751468438253,0.0362935173369488,-0.0139601471365944,0.128310440824245,0.115204292230799
CR2,Complement receptor type 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34549,0.0502421914215392,0.0402198088158316,-0.0285886338574908,0.129073016700569,0.211622871459208
CR2,Complement receptor type 2,Health and medical history,X120098.Mobility problems today,34554,-0.0304452957412375,0.0452206418584002,-0.119077753783702,0.0581871623012269,0.500795796118372
CR2,Complement receptor type 2,Health and medical history,X120099.Self-care problems today,34554,0.130622342628551,0.0708295390495739,-0.00820355390861371,0.269448239165716,0.0651847204844297
CR2,Complement receptor type 2,Health and medical history,X120100.Problems doing usual activities,34554,0.0304228111933434,0.0424518446578309,-0.0527828043360052,0.113628426722692,0.47361014840177
CR2,Complement receptor type 2,Health and medical history,X120101.Pain or discomfort today,34554,0.019599475525448,0.0368646441603602,-0.052655227028858,0.091854178079754,0.594972193601021
CR2,Complement receptor type 2,Health and medical history,X120102.Anxiety or depression today,34554,0.0385175245089069,0.0437878584415255,-0.0473066780364832,0.124341727054297,0.379074471408654
CR2,Complement receptor type 2,Health and medical history,X120103.Scale to indicate how health is today,34520,-0.00581160392317084,0.00498341851653435,-0.0155791042155782,0.0039558963692365,0.243564447941252
CR2,Complement receptor type 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34538,-0.00938173385043037,0.0439339353349217,-0.0954922471068769,0.0767287794060161,0.830908427518002
CR2,Complement receptor type 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34522,-0.0176558046822048,0.044860099158201,-0.105581599032279,0.0702699896678692,0.693902858634279
CR2,Complement receptor type 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34543,-0.0289147749014978,0.036388638846265,-0.100236507040177,0.0424069572371816,0.426858077117332
CR2,Complement receptor type 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34543,0.0376049971523812,0.037131805207798,-0.0351733410549029,0.110383335359665,0.311205598980692
CR2,Complement receptor type 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34540,0.0568951267330329,0.0457359998958973,-0.0327474330629258,0.146537686528992,0.213530548606656
CR2,Complement receptor type 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34513,0.0311620016120616,0.0466070764108145,-0.0601878681531348,0.122511871377258,0.503758175858917
CR2,Complement receptor type 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34545,0.0231803455081667,0.046804225920969,-0.0685559372969326,0.114916628313266,0.620425513378336
CR2,Complement receptor type 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34529,0.0600286962099983,0.0707644569527025,-0.0786696394172987,0.198727031837295,0.396296188429529
CR2,Complement receptor type 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34479,-0.10247469024814,0.0923757646691341,-0.283531188999642,0.0785818085033632,0.267315386405265
CR2,Complement receptor type 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31511,0.0666733384347797,0.0490182001620643,-0.0294023338828663,0.162749010752426,0.173814584207502
CR2,Complement receptor type 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,48957,-0.0936888938163074,0.0515402194405825,-0.194707723919849,0.00732993628723437,0.0691093451468846
CR2,Complement receptor type 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47672,-0.102387276341607,0.0314685346118681,-0.164065604180869,-0.0407089485023458,0.00114095445265326
CR2,Complement receptor type 2,Diet and food preferences,X1289.Cooked vegetable intake,51004,-0.0579058516780753,0.0223444983038271,-0.101701068353576,-0.0141106350025742,0.00956086465096386
CR2,Complement receptor type 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50462,-0.0434463836350043,0.0239376513116588,-0.0903641802058556,0.00347141293584701,0.0695380777749203
CR2,Complement receptor type 2,Diet and food preferences,X1309.Fresh fruit intake,50989,0.110890365439727,0.0237619622885815,0.0643169193541074,0.157463811525347,3.07510856298609e-06
CR2,Complement receptor type 2,Diet and food preferences,X1319.Dried fruit intake,49419,0.063938746692065,0.0249991807791467,0.0149403523649374,0.112937141019193,0.0105444221713397
CR2,Complement receptor type 2,Health and medical history,X134.Number of self-reported cancers,52258,-0.141477060284736,0.0492350583781731,-0.237977774705956,-0.0449763458635172,0.00406248977034703
CR2,Complement receptor type 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52258,0.115876212975129,0.021794708900862,0.0731585835294392,0.158593842420818,1.06456109316635e-07
CR2,Complement receptor type 2,Health and medical history,"X136.Number of operations, self-reported",52258,0.0475595452522758,0.0217253746589418,0.00497781092074999,0.0901412795838017,0.0285959196834023
CR2,Complement receptor type 2,Health and medical history,X137.Number of treatments or medications taken,52258,0.0516707895912594,0.0217797974754454,0.00898238653938644,0.0943591926431323,0.0176786949773881
CR2,Complement receptor type 2,Diet and food preferences,X1438.Bread intake,51389,0.011682977068491,0.0032157837685583,0.00538004088211675,0.0179859132548653,0.000280642405285027
CR2,Complement receptor type 2,Diet and food preferences,X1458.Cereal intake,50625,0.143603008983978,0.0224129949878905,0.0996735388077122,0.187532479160243,1.50747327600029e-10
CR2,Complement receptor type 2,Diet and food preferences,X1488.Tea intake,51164,0.00610770465206045,0.0030448302133993,0.00013983743379781,0.0120755718703231,0.0448739701103255
CR2,Complement receptor type 2,Diet and food preferences,X1498.Coffee intake,49901,-0.0450635447032253,0.0225240921243401,-0.0892107652669319,-0.000916324139518608,0.0454370372673084
CR2,Complement receptor type 2,Diet and food preferences,X1528.Water intake,50228,-0.0239058524856498,0.0230628614605198,-0.0691090609482685,0.0212973559769689,0.299954253508195
CR2,Complement receptor type 2,Lifestyle factors,X1568.Average weekly red wine intake,43126,-0.0792981138923231,0.0264079935999288,-0.131057781348183,-0.0275384464364626,0.00267845010833836
CR2,Complement receptor type 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,43118,-0.138017036507717,0.0272271750677178,-0.191382299640444,-0.0846517733749897,4.03422326172129e-07
CR2,Complement receptor type 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,43169,-0.122178138544606,0.0299061690720897,-0.180794229925902,-0.0635620471633097,4.41818876054356e-05
CR2,Complement receptor type 2,Lifestyle factors,X1598.Average weekly spirits intake,43091,-0.0433233880462521,0.0297715474505709,-0.101675621049371,0.0150288449568669,0.145631784114144
CR2,Complement receptor type 2,Lifestyle factors,X1608.Average weekly fortified wine intake,43161,0.0909168378245173,0.0536096972250334,-0.0141581687365481,0.195991844385583,0.0899204096278276
CR2,Complement receptor type 2,Lifestyle factors,X1737.Childhood sunburn occasions,45712,-0.0413851025642772,0.0261315671177525,-0.0926029741150721,0.00983276898651776,0.11327177435683
CR2,Complement receptor type 2,Health and medical history,X1807.Father's age at death,40790,0.001484723175234,0.00434462512875637,-0.00703074207712849,0.0100001884275965,0.732552370228735
CR2,Complement receptor type 2,Health and medical history,X1845.Mother's age,40064,-0.00756511471473936,0.00649426336563622,-0.0202938709113864,0.00516364148190763,0.244079905979782
CR2,Complement receptor type 2,Health and medical history,X1873.Number of full brothers,51750,0.0121152467670999,0.0217439984760467,-0.0305029902459516,0.0547334837801514,0.57741125891903
CR2,Complement receptor type 2,Health and medical history,X1883.Number of full sisters,51752,-0.0329833640950962,0.0218132288284063,-0.0757372925987725,0.00977056440858021,0.130524643139616
CR2,Complement receptor type 2,Physical measures,X20015.Sitting height,52025,0.0123572795624222,0.00406948319414992,0.0043810925018884,0.0203334666229561,0.00239503505327895
CR2,Complement receptor type 2,Cognitive function,X20016.Fluid intelligence score,32803,-0.0583233085066532,0.0364138831447267,-0.129694519470318,0.0130479024570112,0.109262241515633
CR2,Complement receptor type 2,Cognitive function,X20018.Prospective memory result,33130,0.0298814130012009,0.0516732821542158,-0.0713982200210621,0.131161046023464,0.563091921359407
CR2,Complement receptor type 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),32710,0.0156853750819408,0.00571837110015628,0.00447736772563453,0.0268933824382472,0.00610069917504669
CR2,Complement receptor type 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),32702,0.0126876069930277,0.00568514461532715,0.00154472354698653,0.0238304904390689,0.02565894642124
CR2,Complement receptor type 2,Cognitive function,X20023.Mean time to correctly identify matches,51941,0.00848915335716194,0.0032326492739984,0.00215316078012508,0.0148251459341988,0.00864246847136404
CR2,Complement receptor type 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48975,-0.00145651746722414,0.0070182740835245,-0.0152123346709322,0.0122992997364839,0.835595974484872
CR2,Complement receptor type 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48552,0.0122594755588435,0.0159237900531725,-0.0189511529453747,0.0434701040630616,0.441375907739141
CR2,Complement receptor type 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48516,0.00692657076218278,0.0213287634278587,-0.0348778055564203,0.0487309470807859,0.745371098392249
CR2,Complement receptor type 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48549,-0.00085583424690541,0.0164580955280528,-0.0331137014818889,0.0314020329880781,0.958528471198457
CR2,Complement receptor type 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48551,6.49701365885392e-05,0.0119620108571997,-0.0233805711435228,0.0235105114166999,0.995666456938871
CR2,Complement receptor type 2,Health and medical history,X20107#2.Illnesses of father_Stroke,48712,0.00675598188138521,0.00923478582856303,-0.0113441983425983,0.0248561621053687,0.464432038000695
CR2,Complement receptor type 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48649,-0.00899734063445788,0.0119997834298952,-0.0325169161570524,0.0145222348881367,0.453387152683001
CR2,Complement receptor type 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48552,-0.00971632370381785,0.0144211746409867,-0.0379818260001518,0.0185491785925161,0.50047404840627
CR2,Complement receptor type 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48679,0.00229182803529437,0.0114363345386129,-0.0201233876603869,0.0247070437309756,0.841170318195471
CR2,Complement receptor type 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48835,0.0116598675406467,0.00724719411698863,-0.00254463292865099,0.0258643680099445,0.107655166401021
CR2,Complement receptor type 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48680,0.0297059600064529,0.00989283494887564,0.0103160035066566,0.0490959165062491,0.00267796294547708
CR2,Complement receptor type 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50045,0.0244266540013388,0.00841197631209549,0.00793918042963167,0.040914127573046,0.00368977538184889
CR2,Complement receptor type 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49918,-0.00694592030841019,0.013598280166534,-0.0335985494348169,0.0197067088179965,0.609499618162131
CR2,Complement receptor type 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49862,-0.0246446020321579,0.0286102989756293,-0.0807207880243913,0.0314315839600755,0.389031675332913
CR2,Complement receptor type 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49910,0.0140989649627552,0.012286804204075,-0.00998317127723175,0.0381811012027422,0.251190374090174
CR2,Complement receptor type 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49993,-0.0182428589331077,0.00997672242372234,-0.0377972348836035,0.00131151701738805,0.0674795957803296
CR2,Complement receptor type 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49916,-0.0198831993383017,0.0162882573750763,-0.0518081837934512,0.0120417851168478,0.22220780102597
CR2,Complement receptor type 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49893,-0.0290928139037304,0.0153973587120394,-0.0592716369793276,0.00108600917186692,0.0588402715808922
CR2,Complement receptor type 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49926,-0.0149605713324841,0.0116679488401255,-0.03782975105913,0.0079086083941619,0.199786083656337
CR2,Complement receptor type 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49931,-0.00868088459328407,0.013714639797235,-0.0355615785958647,0.0181998094092966,0.526762164543461
CR2,Complement receptor type 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50149,0.0127894982447742,0.00660646200323932,-0.000159167281574885,0.0257381637711232,0.0528897584413783
CR2,Complement receptor type 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49985,0.0304204359760259,0.010245137228576,0.010339967008017,0.0505009049440349,0.00298792764157037
CR2,Complement receptor type 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,47174,0.0159391371999881,0.0135010995085334,-0.0105230178367373,0.0424012922367136,0.237781387832466
CR2,Complement receptor type 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,47058,0.0907750333199346,0.0763877647824469,-0.0589449856536613,0.240495052293531,0.234709603741313
CR2,Complement receptor type 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,47057,0.0439305649507648,0.064625991817277,-0.0827363790110981,0.170597508912628,0.496659294038758
CR2,Complement receptor type 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,47143,-0.00514129522965356,0.0123623718797472,-0.029371544113958,0.0190889536546509,0.677499753153281
CR2,Complement receptor type 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,47063,-0.0296145046191482,0.0414466941410016,-0.110850025135511,0.051621015897215,0.474912691941731
CR2,Complement receptor type 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,47076,-0.0168772512147963,0.0233037986946824,-0.0625526966563738,0.0287981942267811,0.46893339333627
CR2,Complement receptor type 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,47065,-0.0390209665106524,0.0314517103155571,-0.100666318729144,0.0226243857078395,0.214742890815492
CR2,Complement receptor type 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,47073,-0.0299782033762445,0.027876528624628,-0.0846161994805153,0.0246597927280263,0.282210318613144
CR2,Complement receptor type 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,47078,-0.00923046494500282,0.0187453469547329,-0.0459713449762793,0.0275104150862737,0.622431598979486
CR2,Complement receptor type 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,47082,0.000633720001519875,0.0245943473224763,-0.0475712007505336,0.0488386407535733,0.979443487260693
CR2,Complement receptor type 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,47268,0.0105037338232446,0.00868048763298688,-0.00651002193740973,0.0275174895838988,0.226275915266309
CR2,Complement receptor type 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,47157,0.0350161553408735,0.0126956876964828,0.0101326074557672,0.0598997032259799,0.00581812164629061
CR2,Complement receptor type 2,Mental health,X20127.Neuroticism score,46667,0.0408862366932319,0.0227071743334365,-0.0036198250003036,0.0853922983867674,0.0717812559563172
CR2,Complement receptor type 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32803,-0.0102598813806478,0.03698915604876,-0.0827586272362173,0.0622388644749218,0.781498299850105
CR2,Complement receptor type 2,Lifestyle factors,X20161.Pack years of smoking,31691,0.00083223607347371,0.0067329230925831,-0.0123642931879892,0.0140287653349366,0.901629663344865
CR2,Complement receptor type 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31691,0.000581944987155544,0.00629603431021773,-0.0117582822608712,0.0129221722351823,0.926358449236156
CR2,Complement receptor type 2,Cognitive function,X20191.Fluid intelligence score,31412,0.012345719616024,0.0398322167228014,-0.0657254251606667,0.0904168643927147,0.756612813404409
CR2,Complement receptor type 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31412,0.0585878776154546,0.0406190726245729,-0.0210255047287083,0.138201259959618,0.14923854600429
CR2,Complement receptor type 2,Cognitive function,X20240.Maximum digits remembered correctly,30759,-0.0134424652523807,0.0424491547783301,-0.0966428086179078,0.0697578781131463,0.751501972915736
CR2,Complement receptor type 2,Physical measures,X20255.Spirometry QC measure,45096,0.0020691172762275,0.0293871705651127,-0.0555297370313935,0.0596679715838485,0.943868899756288
CR2,Complement receptor type 2,Eye measures,X20261.avMSE,29956,-0.0147431259095218,0.00712502995917166,-0.0287081846294982,-0.000778067189545329,0.0385691843475108
CR2,Complement receptor type 2,Eye measures,X20262.Myopia diagnosis,29956,0.127352772724351,0.053405248285801,0.0226784860841816,0.232027059364521,0.0171258208350883
CR2,Complement receptor type 2,NMR metabolomics,X20280.Glucose-lactate,39891,0.0177450282371756,0.00417972760226505,0.00955276213673608,0.0259372943376151,2.19335575386029e-05
CR2,Complement receptor type 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,39927,0.0151571187827642,0.00412157203935488,0.00707883758562867,0.0232353999798998,0.000236290620658985
CR2,Complement receptor type 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32715,-0.0014980328451177,0.019749830651192,-0.0402077009214539,0.0372116352312186,0.939539819992689
CR2,Complement receptor type 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32712,0.0438485160350821,0.039894042331739,-0.0343438069351263,0.12204083900529,0.271743692865709
CR2,Complement receptor type 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32710,-0.0332535695296068,0.0434234719761214,-0.118363574602805,0.0518564355435911,0.443817454605905
CR2,Complement receptor type 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32710,0.00368779849675019,0.0190753007814274,-0.0336997910348475,0.0410753880283479,0.846706176576962
CR2,Complement receptor type 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32710,-0.0779842302748056,0.0307097248829259,-0.13817529104534,-0.0177931695042708,0.0111212913669349
CR2,Complement receptor type 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32717,0.0159185351290684,0.0396807317331793,-0.0618556990679629,0.0936927693260998,0.688308058265126
CR2,Complement receptor type 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32717,-0.00626218093428295,0.0260655357029414,-0.057350630912048,0.0448262690434821,0.810143918115348
CR2,Complement receptor type 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32717,0.0166101394442407,0.0283457938508514,-0.038947616503428,0.0721678953919093,0.557902199429212
CR2,Complement receptor type 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32717,-0.0248058574871178,0.0441396231006398,-0.111319518764372,0.0617078037901361,0.574139666630576
CR2,Complement receptor type 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32717,0.0292959363691207,0.0516724788858222,-0.0719821222470908,0.130573994985332,0.570759568485113
CR2,Complement receptor type 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32717,0.0137727627153851,0.0292556869096154,-0.043568383627461,0.0711139090582312,0.637815045830981
CR2,Complement receptor type 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32717,0.117139076563387,0.0504161815718782,0.0183233606825062,0.215954792444269,0.0201779401153822
CR2,Complement receptor type 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32717,0.0525070414672652,0.0381489678891736,-0.0222649355955151,0.127279018530045,0.168742339280837
CR2,Complement receptor type 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32720,0.00686782773791453,0.0508955291893204,-0.0928874094731534,0.106623064948982,0.892662611133144
CR2,Complement receptor type 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32720,0.0219240244857168,0.0255407720473911,-0.0281358887271698,0.0719839376986035,0.390698614211102
CR2,Complement receptor type 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32720,-0.0262408984804989,0.0351290249214495,-0.0950937873265399,0.0426119903655421,0.455091684706981
CR2,Complement receptor type 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32720,-0.0237604063279128,0.0578789940770998,-0.137203234719028,0.0896824220632027,0.68143545466722
CR2,Complement receptor type 2,Diet and food preferences,X20600.Liking for adding salt to foods,35424,-0.00618011851580993,0.0324063902941532,-0.0696966434923501,0.0573364064607302,0.848758672706267
CR2,Complement receptor type 2,Diet and food preferences,X20601.Liking for aniseed,35424,-0.0668639619544267,0.0323843302890381,-0.130337249320941,-0.00339067458791195,0.0389735517755543
CR2,Complement receptor type 2,Diet and food preferences,X20602.Liking for apple juice,35424,0.0241266619721956,0.0326388420415624,-0.0398454684292666,0.0880987923736578,0.459800019472338
CR2,Complement receptor type 2,Diet and food preferences,X20603.Liking for apples,35424,0.0850877716830478,0.0333788036223232,0.0196653165832942,0.150510226782801,0.0108112124819168
CR2,Complement receptor type 2,Diet and food preferences,X20604.Liking for asparagus,35424,-0.0155329667157802,0.0331866830602227,-0.0805788655138168,0.0495129320822564,0.639758961019168
CR2,Complement receptor type 2,Diet and food preferences,X20605.Liking for aubergine,35424,-0.0218577810038374,0.0325552480944909,-0.0856660672690396,0.0419505052613648,0.501975499805464
CR2,Complement receptor type 2,Diet and food preferences,X20606.Liking for avocados,35424,-0.0465522823050762,0.0331092386791404,-0.111446390116191,0.0183418255060389,0.159744801369032
CR2,Complement receptor type 2,Diet and food preferences,X20607.Liking for bacon,35424,-0.096231421776004,0.0330348054002333,-0.160979640360461,-0.0314832031915468,0.00358624350450159
CR2,Complement receptor type 2,Diet and food preferences,X20608.Liking for baked or steamed fish,35424,0.0148114680706088,0.0332413592692179,-0.0503415960970583,0.0799645322382758,0.655913719670198
CR2,Complement receptor type 2,Diet and food preferences,X20609.Liking for bananas,35424,0.00408640432685249,0.0336990033146525,-0.0619636421698664,0.0701364508235714,0.903485724997827
CR2,Complement receptor type 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35424,-0.0638391963255459,0.0329240109571856,-0.12837025780163,0.000691865150537818,0.0525273577699783
CR2,Complement receptor type 2,Diet and food preferences,X20611.Liking for beef steak,35424,-0.107427329876807,0.0329382152723163,-0.171986231810547,-0.0428684279430675,0.00111153546207369
CR2,Complement receptor type 2,Diet and food preferences,X20612.Liking for beetroot,35424,0.00350799405167093,0.0331629239488347,-0.0614913368880451,0.068507324991387,0.915758264149481
CR2,Complement receptor type 2,Diet and food preferences,X20613.Liking for bell pepper,35424,-0.0563330446484228,0.0330231099433629,-0.121058340137414,0.00839225084056849,0.088059656326511
CR2,Complement receptor type 2,Diet and food preferences,X20614.Liking for bicycling,35424,-0.0326085747936281,0.0327293752879453,-0.0967581503580008,0.0315410007707446,0.319120841256173
CR2,Complement receptor type 2,Diet and food preferences,X20615.Liking for biscuits,35424,0.0357806681548767,0.0328539712060403,-0.0286131154089623,0.100174451718716,0.276140446594626
CR2,Complement receptor type 2,Diet and food preferences,X20616.Liking for bitter foods,35424,-0.0766030254572725,0.0327549031978905,-0.140802635725138,-0.012403415189407,0.0193692921732361
CR2,Complement receptor type 2,Diet and food preferences,X20617.Liking for bitter or ale,35424,-0.157509923573798,0.0334500429836764,-0.223072007821803,-0.0919478393257919,2.52064813211093e-06
CR2,Complement receptor type 2,Diet and food preferences,X20618.Liking for black olives,35424,-0.0656150430429181,0.032912992839068,-0.130124509007491,-0.00110557707834476,0.0462202484314962
CR2,Complement receptor type 2,Diet and food preferences,X20619.Liking for black pepper,35424,-0.116983180091069,0.0330726963370457,-0.181805664911678,-0.0521606952704591,0.000406051177873993
CR2,Complement receptor type 2,Diet and food preferences,X20620.Liking for blue cheese,35424,-0.142224671948714,0.0325822414128336,-0.206085865117868,-0.0783634787795606,1.28170403127469e-05
CR2,Complement receptor type 2,Diet and food preferences,X20621.Liking for bolognese sauce,35424,-0.044733323103857,0.0330016044552014,-0.109416467836052,0.0199498216283378,0.175288195225107
CR2,Complement receptor type 2,Diet and food preferences,X20622.Liking for broad beans,35424,0.00917824542488905,0.0328151241172217,-0.0551393978448654,0.0734958886946435,0.779716070072611
CR2,Complement receptor type 2,Diet and food preferences,X20623.Liking for broccoli,35424,0.0610359690153781,0.0337416114023949,-0.00509758933331593,0.127169527364072,0.0704889828922556
CR2,Complement receptor type 2,Diet and food preferences,X20624.Liking for brown rice,35424,0.0349261091840083,0.0327948654721846,-0.0293518271414734,0.0992040455094901,0.286904013527567
CR2,Complement receptor type 2,Diet and food preferences,X20625.Liking for brussel sprouts,35424,0.018819655841041,0.0329490988178387,-0.0457605778419229,0.083399889524005,0.567893070971532
CR2,Complement receptor type 2,Diet and food preferences,X20626.Liking for burgers (meat),35424,-0.0438092294937861,0.0326314158896819,-0.107766804637563,0.0201483456499905,0.179444877154682
CR2,Complement receptor type 2,Diet and food preferences,X20627.Liking for burn of spicy foods,35424,-0.172821834376186,0.0324970459496868,-0.236516044437573,-0.1091276243148,1.06825265996065e-07
CR2,Complement receptor type 2,Diet and food preferences,X20628.Liking for butter on bread,35424,-0.0830987857588894,0.0330716296685888,-0.147919179909323,-0.0182783916084554,0.0119949281540678
CR2,Complement receptor type 2,Diet and food preferences,X20629.Liking for butternut squash,35424,0.0595246229532812,0.0329666979545842,-0.00509010503770378,0.124139350944266,0.0710070799006683
CR2,Complement receptor type 2,Diet and food preferences,X20630.Liking for cabbage,35424,-0.0043293813546522,0.0331026293381891,-0.0692105348575028,0.0605517721481984,0.895946376169264
CR2,Complement receptor type 2,Diet and food preferences,X20631.Liking for cake,35424,0.0483329308134361,0.032934075863993,-0.0162178578799901,0.112883719506862,0.142249359673562
CR2,Complement receptor type 2,Diet and food preferences,X20632.Liking for cake icing,35424,-0.0293437265524473,0.0326163744999509,-0.0932718205723512,0.0345843674674565,0.368318673910408
CR2,Complement receptor type 2,Diet and food preferences,X20633.Liking for capers,35424,-0.0926075268880002,0.0322934248799914,-0.155902639652783,-0.029312414123217,0.00414228808184551
CR2,Complement receptor type 2,Diet and food preferences,X20634.Liking for cauliflower,35424,0.00732993476975335,0.0333241732692664,-0.0579854448380087,0.0726453143775154,0.825907370237133
CR2,Complement receptor type 2,Diet and food preferences,X20635.Liking for cereal or granola bar,35424,-0.0108750014865992,0.0325604443685192,-0.0746934724488968,0.0529434694756983,0.738389951980001
CR2,Complement receptor type 2,Diet and food preferences,X20636.Liking for cheesecake,35424,-0.0297759847800678,0.0327581966769328,-0.093982050266856,0.0344300807067205,0.363388678243617
CR2,Complement receptor type 2,Diet and food preferences,X20637.Liking for cherries,35424,-0.00098896293015137,0.0343403309169457,-0.0682960115273649,0.0663180856670622,0.977025494720138
CR2,Complement receptor type 2,Diet and food preferences,X20638.Liking for chicken,35424,0.0156858443852429,0.0341858423464759,-0.0513184066138498,0.0826900953843357,0.646357436043591
CR2,Complement receptor type 2,Diet and food preferences,X20639.Liking for chilli pepper,35424,-0.140641295679292,0.0327158421897723,-0.204764346371245,-0.0765182449873379,1.73075182558553e-05
CR2,Complement receptor type 2,Diet and food preferences,X20640.Liking for chips or french fries,35424,-0.0490252941925573,0.0329148277865548,-0.113538356654205,0.0154877682690902,0.136393773020177
CR2,Complement receptor type 2,Diet and food preferences,X20641.Liking for cigarette smoking,35424,0.123214181021251,0.0519782550719229,0.0213368010802819,0.22509156096222,0.01778061222681
CR2,Complement receptor type 2,Diet and food preferences,X20642.Liking for cod,35424,0.00554278159664775,0.0334782315274882,-0.0600745521972291,0.0711601153905246,0.868503172262267
CR2,Complement receptor type 2,Diet and food preferences,X20643.Liking for coffee with sugar,35424,0.0393754909268687,0.035660515490046,-0.0305191194336214,0.109270101287359,0.269539723262191
CR2,Complement receptor type 2,Diet and food preferences,X20644.Liking for coffee without sugar,35424,-0.047146551540429,0.0330768655123905,-0.111977207944714,0.0176841048638564,0.154079209945557
CR2,Complement receptor type 2,Diet and food preferences,X20645.Liking for coriander,35424,-0.134804862071086,0.0326537494511808,-0.198806210995401,-0.0708035131467717,3.68003443877237e-05
CR2,Complement receptor type 2,Diet and food preferences,X20646.Liking for corn flakes,35424,0.0774223590550123,0.032610521627526,0.0135057366650615,0.141338981444963,0.0176055157544736
CR2,Complement receptor type 2,Diet and food preferences,X20647.Liking for cream,35424,0.0285489342664483,0.0324622564818067,-0.0350770884378928,0.0921749569707894,0.379175573741525
CR2,Complement receptor type 2,Diet and food preferences,X20648.Liking for croissant,35424,0.0256864897382618,0.0328491344519751,-0.0386978137876094,0.0900707932641329,0.434258029943952
CR2,Complement receptor type 2,Diet and food preferences,X20649.Liking for cucumber,35424,0.00120958665804006,0.0331279184448079,-0.0637211334937834,0.0661403068098635,0.970874257415068
CR2,Complement receptor type 2,Diet and food preferences,X20650.Liking for curry,35424,-0.122317974293287,0.0331147203852545,-0.187222826248386,-0.0574131223381886,0.000221977550410029
CR2,Complement receptor type 2,Diet and food preferences,X20651.Liking for dairy products,35424,0.0408282229233752,0.0331794816949441,-0.0242035611987153,0.105860007045466,0.218525155103252
CR2,Complement receptor type 2,Diet and food preferences,X20652.Liking for dark chocolate,35424,-0.0169634149797576,0.0329806800578682,-0.0816055478931793,0.047678717933664,0.607021339231028
CR2,Complement receptor type 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35424,-0.00885073890384808,0.0334396561544508,-0.0743924649665716,0.0566909871588754,0.791262302983701
CR2,Complement receptor type 2,Diet and food preferences,X20654.Liking for dried fruit,35424,0.0255428716667638,0.0328453298011614,-0.0388339747435126,0.0899197180770402,0.436778713326971
CR2,Complement receptor type 2,Diet and food preferences,X20655.Liking for eggs,35424,-0.0498139287207165,0.0336565823762171,-0.115780830178102,0.016152972736669,0.138883170817693
CR2,Complement receptor type 2,Diet and food preferences,X20656.Liking for exercising alone,35424,-0.0279065623866254,0.0324638405053749,-0.0915356897771601,0.0357225650039094,0.390016451145614
CR2,Complement receptor type 2,Diet and food preferences,X20657.Liking for exercising with others,35424,-0.0178105141068496,0.0327165245449296,-0.0819349022149117,0.0463138740012125,0.586184359986305
CR2,Complement receptor type 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35424,-0.0059590314561062,0.0332928587069251,-0.0712130345216794,0.059294971609467,0.857950043822566
CR2,Complement receptor type 2,Diet and food preferences,X20659.Liking for fatty foods,35424,-0.00172777775313124,0.0324801377478521,-0.0653888477389214,0.061933292232659,0.95757753684494
CR2,Complement receptor type 2,Diet and food preferences,X20660.Liking for fresh tomatoes,35424,-0.0171092108884483,0.0349280948321302,-0.0855682767594235,0.0513498549825269,0.624255755794149
CR2,Complement receptor type 2,Diet and food preferences,X20661.Liking for fried chicken,35424,-0.00865130530743552,0.0326666427293888,-0.0726779250570375,0.0553753144421665,0.791140472019379
CR2,Complement receptor type 2,Diet and food preferences,X20662.Liking for fried or battered fish,35424,-0.06266812389375,0.0326160617275348,-0.126595604879718,0.00125935709221831,0.0547073259422114
CR2,Complement receptor type 2,Diet and food preferences,X20663.Liking for fruit,35424,0.0593852849408344,0.0357227823292905,-0.010631368424575,0.129401938306244,0.0964612276519735
CR2,Complement receptor type 2,Diet and food preferences,X20664.Liking for garlic,35424,-0.0769757579312641,0.0332527323109562,-0.142151113260738,-0.0118004026017899,0.0206374745555425
CR2,Complement receptor type 2,Diet and food preferences,X20665.Liking for gherkins,35424,-0.0860949594656404,0.0325549047080263,-0.149902572693372,-0.0222873462379089,0.00818961884298621
CR2,Complement receptor type 2,Diet and food preferences,X20666.Liking for globe artichoke,35424,-0.00133079163562376,0.0327431178833195,-0.06550730268693,0.0628457194156825,0.967580886757765
CR2,Complement receptor type 2,Diet and food preferences,X20667.Liking for goat's cheese,35424,-0.080858409092069,0.0326795622763148,-0.144910351153646,-0.016806467030492,0.0133647284486136
CR2,Complement receptor type 2,Diet and food preferences,X20668.Liking for going to a cafe,35424,0.0660632120850357,0.0330517109675619,0.00128185858861435,0.130844565581457,0.0456551752501633
CR2,Complement receptor type 2,Diet and food preferences,X20669.Liking for going to the gym,35424,-0.0837537264190649,0.0326827131491707,-0.147811844191439,-0.0196956086466904,0.0104008005540452
CR2,Complement receptor type 2,Diet and food preferences,X20670.Liking for going to the pub,35424,-0.187657278675315,0.032577327624276,-0.251508840818896,-0.123805716531734,8.60738509532806e-09
CR2,Complement receptor type 2,Diet and food preferences,X20671.Liking for grapefruit,35424,-0.0710885155165451,0.0325684900704428,-0.134922756054613,-0.00725427497847722,0.0290750916137077
CR2,Complement receptor type 2,Diet and food preferences,X20672.Liking for green olives,35424,-0.0419465951561902,0.0329826619802125,-0.106592612637407,0.0226994223250262,0.203477913012074
CR2,Complement receptor type 2,Diet and food preferences,X20673.Liking for haddock,35424,-0.0158064121842756,0.033370798495726,-0.0812131772358986,0.0496003528673474,0.635751335440335
CR2,Complement receptor type 2,Diet and food preferences,X20674.Liking for ham,35424,-0.0463989505291047,0.0328497890158344,-0.11078453700014,0.0179866359419306,0.157842051631986
CR2,Complement receptor type 2,Diet and food preferences,X20675.Liking for hard cheese,35424,-0.0214526785937592,0.033644326006239,-0.0873955575659876,0.0444902003784692,0.523726286824018
CR2,Complement receptor type 2,Diet and food preferences,X20676.Liking for herring,35424,-0.0313703361425617,0.0323697444788602,-0.0948150353211276,0.0320743630360042,0.332502993880848
CR2,Complement receptor type 2,Diet and food preferences,X20677.Liking for honey,35424,-0.0409490379456105,0.0328358190723239,-0.105307243327365,0.0234091674361443,0.212391826131719
CR2,Complement receptor type 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35424,-0.091754896395411,0.0325679441917706,-0.155588067011281,-0.0279217257795406,0.00485057620941266
CR2,Complement receptor type 2,Diet and food preferences,X20679.Liking for ice cream,35424,0.0332423683289665,0.0329247993059115,-0.03129023831062,0.0977749749685531,0.312686407259277
CR2,Complement receptor type 2,Diet and food preferences,X20680.Liking for jam,35424,0.0426048906082448,0.0327161057510858,-0.0215186766638835,0.106728457880373,0.192853322962338
CR2,Complement receptor type 2,Diet and food preferences,X20681.Liking for kiwi fruit,35424,0.0545486112806927,0.0328455353955562,-0.00982863809459741,0.118925860655983,0.0967884221664551
CR2,Complement receptor type 2,Diet and food preferences,X20682.Liking for lager,35424,-0.156322677207631,0.0327303395908151,-0.220474142805629,-0.0921712116096337,1.80942931521597e-06
CR2,Complement receptor type 2,Diet and food preferences,X20683.Liking for lamb,35424,-0.0342561306700569,0.0328377208934413,-0.0986180636212018,0.030105802281088,0.296880032566136
CR2,Complement receptor type 2,Diet and food preferences,X20684.Liking for lemons,35424,-0.0314678364326103,0.0329409482575956,-0.0960320950174976,0.033096422152277,0.339455989712682
CR2,Complement receptor type 2,Diet and food preferences,X20685.Liking for lentils or beans,35424,-0.010913260369778,0.0328773156155751,-0.0753527989763052,0.0535262782367493,0.739941407711838
CR2,Complement receptor type 2,Diet and food preferences,X20686.Liking for liver,35424,-0.0193167128787815,0.0328697287772983,-0.0837413812822861,0.0451079555247231,0.556762044591521
CR2,Complement receptor type 2,Diet and food preferences,X20687.Liking for mackerel,35424,-0.034980566445744,0.0327243841999459,-0.099120359477638,0.02915922658615,0.285116788786723
CR2,Complement receptor type 2,Diet and food preferences,X20688.Liking for marzipan,35424,-0.00551365879316449,0.0326507653619775,-0.0695091589026403,0.0584818413163113,0.865903682361735
CR2,Complement receptor type 2,Diet and food preferences,X20689.Liking for mayonnaise,35424,-0.0243994308990616,0.0328316340077095,-0.0887494335541721,0.039950571756049,0.457394878493944
CR2,Complement receptor type 2,Diet and food preferences,X20690.Liking for melon,35424,0.0388531228877723,0.0335886035027761,-0.0269805399776688,0.104686785753213,0.247404441444655
CR2,Complement receptor type 2,Diet and food preferences,X20691.Liking for milk chocolate,35424,-0.0248832352658264,0.0328797874601462,-0.0893276186877129,0.03956114815606,0.449188546899356
CR2,Complement receptor type 2,Diet and food preferences,X20692.Liking for mushrooms,35424,-0.0240439076739442,0.0337173452491552,-0.0901299043622884,0.0420420890144,0.475797018004411
CR2,Complement receptor type 2,Diet and food preferences,X20694.Liking for orange juice,35424,-0.031294775363015,0.0327437569952252,-0.0954725390736565,0.0328829883476264,0.339219635497755
CR2,Complement receptor type 2,Diet and food preferences,X20695.Liking for oranges,35424,0.033212051295084,0.0332235224348546,-0.031906052677231,0.098330155267399,0.317498561058836
CR2,Complement receptor type 2,Diet and food preferences,X20696.Liking for pasta,35424,0.0758823442925357,0.0329550534483066,0.0112904395338547,0.140474249051217,0.0213189766687447
CR2,Complement receptor type 2,Diet and food preferences,X20697.Liking for pears,35424,0.0953771831531832,0.0332025842367232,0.0303001180492058,0.160454248257161,0.00407872202225895
CR2,Complement receptor type 2,Diet and food preferences,X20698.Liking for pizza,35424,0.0232582688228887,0.0327992694081158,-0.0410282992170183,0.0875448368627957,0.478270923801322
CR2,Complement receptor type 2,Diet and food preferences,X20699.Liking for plain yogurt,35424,-0.00485523765560724,0.0327073959696801,-0.0689617337561802,0.0592512584449657,0.881994462113089
CR2,Complement receptor type 2,Diet and food preferences,X20700.Liking for plums,35424,0.0773869084582109,0.0334382756757198,0.0118478881338001,0.142925928782622,0.0206675597718935
CR2,Complement receptor type 2,Diet and food preferences,X20701.Liking for pollock,35424,-0.0502381586585948,0.0325692140889589,-0.114073818272954,0.0135975009557646,0.122978433976724
CR2,Complement receptor type 2,Diet and food preferences,X20702.Liking for pork chop,35424,-0.0390041091941036,0.0327423969203057,-0.103179207157903,0.0251709887696957,0.233583174250106
CR2,Complement receptor type 2,Diet and food preferences,X20703.Liking for porridge,35424,0.0709707235868607,0.0330349233257965,0.0062222738682995,0.135719173305422,0.0317063313919554
CR2,Complement receptor type 2,Diet and food preferences,X20704.Liking for potato crisps,35424,-0.000928407372533112,0.0329823340308442,-0.0655737820729878,0.0637169673279216,0.977544097898293
CR2,Complement receptor type 2,Diet and food preferences,X20705.Liking for potatoes,35424,0.0115202872175856,0.0332441850210931,-0.0536383154237569,0.0766788898589281,0.728946688426308
CR2,Complement receptor type 2,Diet and food preferences,X20706.Liking for prawns,35424,-0.0442796248584121,0.033161341132598,-0.109275853478304,0.02071660376148,0.181811525952807
CR2,Complement receptor type 2,Diet and food preferences,X20707.Liking for raw carrots,35424,0.0312656924412552,0.0331065841010639,-0.03362321239683,0.0961545972793404,0.344987582377392
CR2,Complement receptor type 2,Diet and food preferences,X20708.Liking for red meat,35424,-0.0563003463523323,0.0327504982691193,-0.120491322959806,0.00789063025514158,0.0856287025508504
CR2,Complement receptor type 2,Diet and food preferences,X20709.Liking for red wine,35424,-0.184041697031815,0.0327894827003842,-0.248309083124568,-0.119774310939062,2.03633478424817e-08
CR2,Complement receptor type 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35424,-0.0222280739002058,0.0337189149571939,-0.0883171472163059,0.0438609994158942,0.50976972209209
CR2,Complement receptor type 2,Diet and food preferences,X20711.Liking for roast chicken,35424,0.0351584463447893,0.0342662557960226,-0.0320034150154151,0.102320307704994,0.304895621569443
CR2,Complement receptor type 2,Diet and food preferences,X20712.Liking for salad dressing,35424,-0.057720034702273,0.032753454862769,-0.1219168062333,0.00647673682875432,0.0780521685401045
CR2,Complement receptor type 2,Diet and food preferences,X20713.Liking for salad leaves,35424,0.0709123990303078,0.0335936857285595,0.00506877500233116,0.136756023058284,0.0348036424586078
CR2,Complement receptor type 2,Diet and food preferences,X20714.Liking for salami,35424,-0.0802725686700449,0.0325365818524296,-0.144044269100807,-0.0165008682392828,0.0136337899481752
CR2,Complement receptor type 2,Diet and food preferences,X20715.Liking for salmon,35424,0.0201363772568936,0.0340963882321346,-0.0466925436780901,0.0869652981918774,0.554818680721991
CR2,Complement receptor type 2,Diet and food preferences,X20716.Liking for salty foods,35424,-0.0106525564171234,0.0326778759091628,-0.0747011931990825,0.0533960803648357,0.744440240345918
CR2,Complement receptor type 2,Diet and food preferences,X20717.Liking for salty pretzels,35424,-0.0208246775933994,0.0326900860398022,-0.0848972462314116,0.0432478910446129,0.524115689728969
CR2,Complement receptor type 2,Diet and food preferences,X20718.Liking for sardines,35424,-0.0279195485009227,0.0324967802587907,-0.0916132378081524,0.0357741408063071,0.390276610193604
CR2,Complement receptor type 2,Diet and food preferences,X20719.Liking for sausages (meat),35424,-0.0412593372787096,0.0329059731429873,-0.105755044638965,0.0232363700815456,0.209919877637503
CR2,Complement receptor type 2,Diet and food preferences,X20720.Liking for savoury biscuits,35424,-0.0766887666148304,0.0330611281503807,-0.141488577789577,-0.0118889554400842,0.0203795819457048
CR2,Complement receptor type 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35424,-0.0956325403236666,0.0324831146500816,-0.159299445037826,-0.0319656356095067,0.00324572326581533
CR2,Complement receptor type 2,Diet and food preferences,X20722.Liking for skimmed milk,35424,-0.0049949938525512,0.03270228016004,-0.0690914629662297,0.0591014752611273,0.878604834903433
CR2,Complement receptor type 2,Diet and food preferences,X20723.Liking for smoked fish,35424,-0.0529162751166189,0.0327292043506835,-0.117065515643959,0.0112329654107209,0.105950752552564
CR2,Complement receptor type 2,Diet and food preferences,X20724.Liking for soft cheese,35424,-0.0440030015516431,0.0327120199947679,-0.108118560741388,0.0201125576381021,0.178598974734153
CR2,Complement receptor type 2,Diet and food preferences,X20725.Liking for soy sauce,35424,-0.0619001569604251,0.0328578358555606,-0.126301515237324,0.00250120131647365,0.0596065539575672
CR2,Complement receptor type 2,Diet and food preferences,X20726.Liking for soya milk,35424,0.066340942313536,0.0328696860326047,0.00191635768963083,0.130765526937441,0.0435829130804741
CR2,Complement receptor type 2,Diet and food preferences,X20727.Liking for spicy foods,35424,-0.172783815470236,0.0328553364464602,-0.237180274905298,-0.108387356035174,1.47486041780495e-07
CR2,Complement receptor type 2,Diet and food preferences,X20728.Liking for spinach,35424,0.00812640209564819,0.0331549613117021,-0.0568573220752878,0.0731101262665842,0.806380527940662
CR2,Complement receptor type 2,Diet and food preferences,X20729.Liking for spirits,35424,-0.17287992433229,0.0325672594850756,-0.236711752923038,-0.109048095741541,1.12642383213558e-07
CR2,Complement receptor type 2,Diet and food preferences,X20730.Liking for strawberries,35424,0.0835856215856213,0.0357300259757223,0.0135547706732056,0.153616472498037,0.0193334225675065
CR2,Complement receptor type 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35424,0.0256791069736778,0.0334927376887715,-0.0399666588963144,0.09132487284367,0.443271572356381
CR2,Complement receptor type 2,Diet and food preferences,X20732.Liking for sweet foods,35424,0.0292899078285483,0.0326868759120757,-0.03477636895912,0.0933561846162166,0.370231121856232
CR2,Complement receptor type 2,Diet and food preferences,X20733.Liking for taking the stairs,35424,0.0103030578440462,0.0335823411501976,-0.055518330810341,0.0761244464984335,0.759001236725292
CR2,Complement receptor type 2,Diet and food preferences,X20734.Liking for tea with sugar,35424,0.0430978326457478,0.0393449889577322,-0.0340183457114073,0.120214011002903,0.273371702381016
CR2,Complement receptor type 2,Diet and food preferences,X20735.Liking for tea without sugar,35424,0.0458202535326455,0.0342882555141848,-0.0213847272751566,0.113025234340448,0.181469377741149
CR2,Complement receptor type 2,Diet and food preferences,X20736.Liking for tomato ketchup,35424,-0.0230596693936056,0.0325709340882502,-0.086898700206576,0.0407793614193647,0.478970061059074
CR2,Complement receptor type 2,Diet and food preferences,X20737.Liking for tinned tuna,35424,-0.00199674039381328,0.0329264896156913,-0.0665326600405682,0.0625391792529417,0.95164507730963
CR2,Complement receptor type 2,Diet and food preferences,X20738.Liking for turnip (white),35424,-0.0382363570866874,0.0327441044150328,-0.102414801740152,0.0259420875667769,0.242938750496237
CR2,Complement receptor type 2,Diet and food preferences,X20739.Liking for vegetables,35424,0.0358013525180599,0.0360494420736454,-0.034855553946285,0.106458258982405,0.320673212192923
CR2,Complement receptor type 2,Diet and food preferences,X20740.Liking for vinegar,35424,-0.0286045020187517,0.0328746770596602,-0.0930388690556858,0.0358298650181823,0.384259751460916
CR2,Complement receptor type 2,Diet and food preferences,X20741.Liking for watching television,35424,0.078299331522667,0.0331372094439405,0.0133504010125437,0.14324826203279,0.0181498883444861
CR2,Complement receptor type 2,Diet and food preferences,X20742.Liking for whisky,35424,-0.145738066809928,0.0337696262832154,-0.211926534325031,-0.0795495992948261,1.60454368396338e-05
CR2,Complement receptor type 2,Diet and food preferences,X20743.Liking for white bread,35424,0.00832897690459156,0.0325844843820333,-0.0555366124841937,0.0721945662933768,0.798255198351587
CR2,Complement receptor type 2,Diet and food preferences,X20744.Liking for white rice,35424,0.0102842702727608,0.0330676225160842,-0.0545282698587642,0.0750968104042858,0.755800721766291
CR2,Complement receptor type 2,Diet and food preferences,X20745.Liking for white wine,35424,-0.168738722535926,0.0325879026698029,-0.232611011768739,-0.104866433303112,2.28101365674786e-07
CR2,Complement receptor type 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35424,0.0642352795312532,0.0329766079673966,-0.000398872084844029,0.12886943114735,0.0514505859571347
CR2,Complement receptor type 2,Diet and food preferences,X20747.Liking for whole milk,35424,0.00439567671471571,0.0324070970287908,-0.0591222334617142,0.0679135868911456,0.892108779854362
CR2,Complement receptor type 2,Diet and food preferences,X20748.Liking for wholemeal bread,35424,-0.00380038861853909,0.0340229313477063,-0.0704853340600434,0.0628845568229652,0.911062585883353
CR2,Complement receptor type 2,Diet and food preferences,X20749.Liking for working up a sweat,35424,-0.0916287323578611,0.0328354165265005,-0.155986148749802,-0.02727131596592,0.00527055314456252
CR2,Complement receptor type 2,Physical measures,X21001.Body mass index (BMI),52124,-0.0404934115859013,0.012813854659329,-0.0656085667181861,-0.0153782564536164,0.00157866505921763
CR2,Complement receptor type 2,Physical measures,X21002.Weight,52145,0.0161179489066778,0.00746893219390676,0.00147884180662059,0.0307570560067351,0.0309362915602372
CR2,Complement receptor type 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,33048,0.00882646262912342,0.00593559126987798,-0.00280729625983742,0.0204602215180843,0.137038517176089
CR2,Complement receptor type 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34791,0.0137413623822815,0.0348116958422311,-0.0544895614684914,0.0819722862330545,0.693046861111478
CR2,Complement receptor type 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34791,-0.0406606420316222,0.0364233913872576,-0.112050489150647,0.0307292050874027,0.264304069011855
CR2,Complement receptor type 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34791,0.0738975620302292,0.0358958453606539,0.00354170512334756,0.144253418937111,0.0395498803687603
CR2,Complement receptor type 2,Health and medical history,X21040.Satisfaction with bowel habits,34760,0.000449874300773417,0.0333541442731498,-0.0649242484746002,0.065823997076147,0.989238859414658
CR2,Complement receptor type 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34760,0.0348374665598198,0.0352000302673358,-0.0341545927641584,0.103829525883798,0.322342809162118
CR2,Complement receptor type 2,Health and medical history,X21042.Greatest number of times bowels opened per day,34750,-0.0272948673194951,0.0363031834832844,-0.0984491069467325,0.0438593723077422,0.452152238048477
CR2,Complement receptor type 2,Health and medical history,X21043.Least number of times bowels opened per week,34690,-0.00154406438110389,0.035662590527159,-0.0714427418143356,0.0683546130521278,0.965466001139386
CR2,Complement receptor type 2,Health and medical history,X21044.Average number of times bowels opened per day,34724,-0.0132041688686852,0.0401336331366284,-0.0918660898164769,0.0654577520791065,0.742158200748885
CR2,Complement receptor type 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34796,-0.0376245910931156,0.0364137659631271,-0.108995572380845,0.0337463901946136,0.301508903944043
CR2,Complement receptor type 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34791,0.0152638050268096,0.0364766353816403,-0.0562304003212054,0.0867580103748246,0.675623212415201
CR2,Complement receptor type 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,30247,0.0227055296799761,0.0525859467315901,-0.0803629259139405,0.125773985273893,0.665916313888128
CR2,Complement receptor type 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34793,-0.0415830363467978,0.0384142291069949,-0.116874925396508,0.0337088527029123,0.279058530349304
CR2,Complement receptor type 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34791,0.0310730984112569,0.0550970777585402,-0.076917173995482,0.139063370817996,0.572786126902334
CR2,Complement receptor type 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34794,0.00709472706025962,0.0433559727109659,-0.0778829794532335,0.0920724335737527,0.870018383072585
CR2,Complement receptor type 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34792,-0.0108870939059726,0.107258608801638,-0.221113967157182,0.199339779345237,0.919152865195671
CR2,Complement receptor type 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34794,-0.010425501717094,0.0408598879465608,-0.0905108820923533,0.0696598786581653,0.79861013189568
CR2,Complement receptor type 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34794,-0.0620392938832984,0.0429635497687902,-0.146247851430127,0.0221692636635303,0.148768101050286
CR2,Complement receptor type 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34545,0.0465010134076126,0.0381497264010015,-0.0282724503383504,0.121274477153576,0.222905960288325
CR2,Complement receptor type 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34794,-0.0347771788118879,0.0378844322667443,-0.109030666054707,0.039476308430931,0.358649204320379
CR2,Complement receptor type 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34795,-0.0636357601543747,0.0518942320411499,-0.165348454955028,0.0380769346462791,0.22012769741203
CR2,Complement receptor type 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34793,-0.0742586623649859,0.0363795647412616,-0.145562609257859,-0.00295471547211311,0.0412530168268869
CR2,Complement receptor type 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34791,-0.0411881208069467,0.0363170377462059,-0.11236951478951,0.0299932731756168,0.256766294129782
CR2,Complement receptor type 2,Working and living environment,X21100.Water hardness (USGS classification),51882,0.0475274388288322,0.0220775122528591,0.00425551481322827,0.0907993628444361,0.03134657686402
CR2,Complement receptor type 2,Lifestyle factors,X2139.Age first had sexual intercourse,49166,0.024228973764563,0.0034416634144202,0.0174833134722994,0.0309746340568266,1.97284933702764e-12
CR2,Complement receptor type 2,Health and medical history,X2149.Lifetime number of sexual partners,47139,-0.118274028505684,0.0248815850112863,-0.167041935127805,-0.0695061218835626,2.01143034877695e-06
CR2,Complement receptor type 2,Physical activities,X22032.IPAQ activity group,47113,-0.0927071746394926,0.0241969733263638,-0.140133242359166,-0.0452811069198196,0.000127774810263504
CR2,Complement receptor type 2,Physical activities,X22033.Summed days activity,47697,-0.0163586736691059,0.00330466126371898,-0.0228358097459951,-0.00988153759221675,7.46500648321638e-07
CR2,Complement receptor type 2,Physical activities,X22034.Summed minutes activity,47113,-0.0109822363059803,0.00337919794942848,-0.0176054642868601,-0.00435900832510042,0.00115587907033977
CR2,Complement receptor type 2,Physical activities,X22037.MET minutes per week for walking,46338,-0.00502149167715212,0.00331743194048333,-0.0115236582804995,0.00148067492619521,0.130124039992258
CR2,Complement receptor type 2,Physical activities,X22038.MET minutes per week for moderate activity,47113,-0.0125799785397425,0.00345883578178219,-0.0193592966720356,-0.00580066040744944,0.000276368133074038
CR2,Complement receptor type 2,Physical activities,X22039.MET minutes per week for vigorous activity,47113,-0.141146485767484,0.0241506563664665,-0.188481772245758,-0.0938111992892098,5.15132215350038e-09
CR2,Complement receptor type 2,Physical activities,X22040.Summed MET minutes per week for all activity,46338,-0.0136847674188802,0.0034186645122917,-0.0203853498629719,-0.00698418497478848,6.27563500450218e-05
CR2,Complement receptor type 2,Eye measures,X2217.Age started wearing glasses or contact lenses,46485,-0.0117290575091344,0.0039809509424029,-0.0195317213562441,-0.00392639366202469,0.00321932885347944
CR2,Complement receptor type 2,Working and living environment,X22501.Year ended full time education,31403,-0.0169677691989277,0.0168580914014452,-0.0500096283457602,0.0160740899479049,0.314204539613484
CR2,Complement receptor type 2,Lifestyle factors,X22506.Tobacco smoking,31352,0.00774518703542677,0.0881919656448555,-0.16511106562849,0.180601439699344,0.930020569661087
CR2,Complement receptor type 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50190,-0.204863128949956,0.048495808960047,-0.299914914511648,-0.109811343388263,2.40439739345254e-05
CR2,Complement receptor type 2,Physical measures,X23098.Weight,51766,0.0183256204828718,0.00751057040007506,0.00360490249872472,0.0330463384670189,0.0146943696440227
CR2,Complement receptor type 2,Physical measures,X23099.Body fat percentage,51744,0.0119321778158104,0.00728685867534268,-0.00235006518786129,0.026214420819482,0.10153884893978
CR2,Complement receptor type 2,Physical measures,X23100.Whole body fat mass,51710,0.0186725636712359,0.00692229245749398,0.00510487045454769,0.0322402568879241,0.00699140535692209
CR2,Complement receptor type 2,Physical measures,X23101.Whole body fat-free mass,51761,0.00962234601270165,0.00641931375168435,-0.00295950894059967,0.022204200966003,0.133893242933178
CR2,Complement receptor type 2,Physical measures,X23102.Whole body water mass,51766,0.00937857701076402,0.00641886671156559,-0.00320240174390454,0.0219595557654326,0.144000505019286
CR2,Complement receptor type 2,Physical measures,X23104.Body mass index (BMI),51766,-0.0423418029440658,0.0128975515133157,-0.0676210039101646,-0.017062601977967,0.00102859202019108
CR2,Complement receptor type 2,Physical measures,X23105.Basal metabolic rate,51764,0.0114836076891522,0.00687797320684239,-0.00199721979625885,0.0249644351745633,0.0950056131507326
CR2,Complement receptor type 2,Physical measures,X23106.Impedance of whole body,51763,0.0125309319538568,0.00528492336446257,0.00217248215951021,0.0228893817482035,0.017743343815942
CR2,Complement receptor type 2,Physical measures,X23107.Impedance of leg (right),51763,0.010141478351863,0.00435732647463722,0.00160111846157408,0.018681838242152,0.0199482122177784
CR2,Complement receptor type 2,Physical measures,X23108.Impedance of leg (left),51762,0.00929005108886179,0.00432511069566055,0.000812834125367118,0.0177672680523565,0.0317276054450203
CR2,Complement receptor type 2,Physical measures,X23109.Impedance of arm (right),51756,0.00858349011311219,0.00530147154756087,-0.00180739412010712,0.0189743743463315,0.105442022993916
CR2,Complement receptor type 2,Physical measures,X23110.Impedance of arm (left),51761,0.0098072576060405,0.00529334612022148,-0.000567700789593594,0.0201822160016746,0.0639284654764773
CR2,Complement receptor type 2,Physical measures,X23111.Leg fat percentage (right),51762,0.0145134721532085,0.0090211708137478,-0.0031680226417372,0.0321949669481542,0.107666240942999
CR2,Complement receptor type 2,Physical measures,X23112.Leg fat mass (right),51761,0.0338788215799282,0.00934560968715103,0.0155614265931121,0.0521962165667442,0.00028935715284914
CR2,Complement receptor type 2,Physical measures,X23113.Leg fat-free mass (right),51761,0.0130086218409596,0.00690309969733414,-0.000521453565815287,0.0265386972477345,0.059513037501972
CR2,Complement receptor type 2,Physical measures,X23114.Leg predicted mass (right),51760,0.013256238632584,0.00692949724788785,-0.000325575973276208,0.0268380532384442,0.055756238144504
CR2,Complement receptor type 2,Physical measures,X23115.Leg fat percentage (left),51759,0.0110844296843611,0.00933568191784557,-0.00721350687461618,0.0293823662433384,0.235112045037763
CR2,Complement receptor type 2,Physical measures,X23116.Leg fat mass (left),51759,0.030686557098909,0.00971815013769765,0.0116389828290216,0.0497341313687964,0.00159213518577829
CR2,Complement receptor type 2,Physical measures,X23117.Leg fat-free mass (left),51757,0.017619690595978,0.00715757415912539,0.00359084524409219,0.0316485359478637,0.0138346234148897
CR2,Complement receptor type 2,Physical measures,X23118.Leg predicted mass (left),51756,0.0172411385570883,0.00718397892359017,0.0031605398668516,0.0313217372473251,0.0164041466825165
CR2,Complement receptor type 2,Physical measures,X23119.Arm fat percentage (right),51756,-0.00401583451554387,0.00802515577377657,-0.019745139832146,0.0117134708010582,0.616793316042368
CR2,Complement receptor type 2,Physical measures,X23120.Arm fat mass (right),51753,0.00812176089598651,0.00784213852958649,-0.007248830622003,0.023492352413976,0.300371451833711
CR2,Complement receptor type 2,Physical measures,X23121.Arm fat-free mass (right),51753,0.0128777547845425,0.00642318300371819,0.000288316097254824,0.0254671934718301,0.0449847959213067
CR2,Complement receptor type 2,Physical measures,X23122.Arm predicted mass (right),51752,0.0145868204803931,0.00642977866093541,0.00198445430495973,0.0271891866558266,0.023298142832312
CR2,Complement receptor type 2,Physical measures,X23123.Arm fat percentage (left),51748,-0.00130711050380893,0.00820450162911989,-0.0173879336968839,0.0147737126892661,0.873420865497046
CR2,Complement receptor type 2,Physical measures,X23124.Arm fat mass (left),51747,0.0056728944655334,0.00780944946078973,-0.00963362647761447,0.0209794154086813,0.467591026095403
CR2,Complement receptor type 2,Physical measures,X23125.Arm fat-free mass (left),51743,0.00943705883708846,0.0065268049344195,-0.00335547883437376,0.0222295965085507,0.148218572449448
CR2,Complement receptor type 2,Physical measures,X23126.Arm predicted mass (left),51742,0.00806124146984825,0.00656242102960403,-0.00480110374817565,0.0209235866878721,0.219309304635216
CR2,Complement receptor type 2,Physical measures,X23127.Trunk fat percentage,51739,0.0090216777282053,0.00522100954443564,-0.00121150097888855,0.0192548564352991,0.0840070851441973
CR2,Complement receptor type 2,Physical measures,X23128.Trunk fat mass,51735,0.016840963965263,0.00569033243042636,0.00568791240162732,0.0279940155288987,0.00308323046267858
CR2,Complement receptor type 2,Physical measures,X23129.Trunk fat-free mass,51729,0.00572405697015206,0.00584712872758012,-0.00573631533590497,0.0171844292762091,0.327612312364825
CR2,Complement receptor type 2,Physical measures,X23130.Trunk predicted mass,51727,0.00671547843520874,0.00583847521502949,-0.00472793298624906,0.0181588898566665,0.250066845551256
CR2,Complement receptor type 2,NMR metabolomics,X23400.Total Cholesterol,39931,-0.0247187477919022,0.00440558394338144,-0.0333536923209298,-0.0160838032628746,2.04743394930531e-08
CR2,Complement receptor type 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39931,-0.00587981208205062,0.00428104963994427,-0.0142706693763414,0.00251104521224016,0.169631330856915
CR2,Complement receptor type 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39931,0.000770125654174844,0.00429883998843445,-0.00765560072315668,0.00919585203150637,0.857824286964383
CR2,Complement receptor type 2,NMR metabolomics,X23403.VLDL Cholesterol,39931,0.0174739027504759,0.00423391778570537,0.00917542389049337,0.0257723816104584,3.69180735709148e-05
CR2,Complement receptor type 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,39931,-0.0108684014190655,0.00427877897779992,-0.0192548082155534,-0.00248199462257766,0.0110923365317432
CR2,Complement receptor type 2,NMR metabolomics,X23405.LDL Cholesterol,39931,-0.0115709433079494,0.00424261229783399,-0.019886463411704,-0.00325542320419475,0.00639212083355175
CR2,Complement receptor type 2,NMR metabolomics,X23406.HDL Cholesterol,39931,-0.067506309775212,0.00481500619114684,-0.0769437219098598,-0.0580688976405642,2.14833633002101e-44
CR2,Complement receptor type 2,NMR metabolomics,X23407.Total Triglycerides,39931,0.0147031945561601,0.00434175511852652,0.00619335452384815,0.0232130345884721,0.000709693364005732
CR2,Complement receptor type 2,NMR metabolomics,X23408.Triglycerides in VLDL,39931,0.0194313983094255,0.00441035740709317,0.0107870977915229,0.0280756988273281,1.06048859475371e-05
CR2,Complement receptor type 2,NMR metabolomics,X23409.Triglycerides in LDL,39931,-0.00160771929632006,0.00414806345055814,-0.00973792365941402,0.00652248506677391,0.69832970936463
CR2,Complement receptor type 2,NMR metabolomics,X23410.Triglycerides in HDL,39931,0.00140514749657312,0.0041054013888616,-0.00664143922559562,0.00945173421874185,0.732153695759298
CR2,Complement receptor type 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39931,-0.0348106074947599,0.0043586292383927,-0.0433535208020095,-0.0262676941875102,1.48046164603183e-15
CR2,Complement receptor type 2,NMR metabolomics,X23412.Phospholipids in VLDL,39931,0.0196394542516164,0.00427783242936989,0.0112549026900514,0.0280240058131814,4.44506952038704e-06
CR2,Complement receptor type 2,NMR metabolomics,X23413.Phospholipids in LDL,39931,-0.00975940966223654,0.00424701333183084,-0.018083555792625,-0.00143526353184809,0.0215776117752491
CR2,Complement receptor type 2,NMR metabolomics,X23414.Phospholipids in HDL,39931,-0.0590268635570491,0.0045307713772875,-0.0679071754565326,-0.0501465516575656,1.33037118313163e-38
CR2,Complement receptor type 2,NMR metabolomics,X23415.Total Esterified Cholesterol,39931,-0.028652413563797,0.00442059377726574,-0.0373167773672378,-0.0199880497603562,9.34123310558881e-11
CR2,Complement receptor type 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39931,0.0159597129991376,0.00423450389063274,0.00766008537349746,0.0242593406247778,0.000164509482531922
CR2,Complement receptor type 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39931,-0.0101088490023976,0.00422631973519011,-0.0183924356833702,-0.00182526232142497,0.0167737509954411
CR2,Complement receptor type 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39931,-0.068816948284867,0.00480458212340801,-0.0782339292467466,-0.0593999673229873,3.01938474527358e-46
CR2,Complement receptor type 2,NMR metabolomics,X23419.Total Free Cholesterol,39931,-0.0145991021149327,0.0043641715128359,-0.023152878280091,-0.00604532594977433,0.000824063151627632
CR2,Complement receptor type 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,39931,0.0189360268358966,0.0042570884144383,0.0105921335435975,0.0272799201281956,8.72077766664059e-06
CR2,Complement receptor type 2,NMR metabolomics,X23421.Free Cholesterol in LDL,39931,-0.0152223461517503,0.00429480231047683,-0.0236401586802849,-0.00680453362321574,0.000394677652430674
CR2,Complement receptor type 2,NMR metabolomics,X23422.Free Cholesterol in HDL,39931,-0.0588136941059635,0.00478120897346991,-0.0681848636939645,-0.0494425245179624,1.28034655572782e-34
CR2,Complement receptor type 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39931,-0.0175481753913589,0.00425235042674901,-0.025882782227787,-0.00921356855493083,3.69860346771125e-05
CR2,Complement receptor type 2,NMR metabolomics,X23424.Total Lipids in VLDL,39931,0.0203129721526317,0.00431754798889252,0.0118505780944024,0.028775366210861,2.56296880510285e-06
CR2,Complement receptor type 2,NMR metabolomics,X23425.Total Lipids in LDL,39931,-0.0106774465005894,0.00423756423538152,-0.0189830724019372,-0.00237182059924159,0.0117546614121956
CR2,Complement receptor type 2,NMR metabolomics,X23426.Total Lipids in HDL,39931,-0.0613826210305913,0.00462772348315282,-0.0704529590575708,-0.0523122830036118,6.06255547404596e-40
CR2,Complement receptor type 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39931,-0.060533307347055,0.00436074640627731,-0.0690803703033585,-0.0519862443907514,1.46506572834721e-43
CR2,Complement receptor type 2,NMR metabolomics,X23428.Concentration of VLDL Particles,39931,0.0164433531491051,0.00422451175185668,0.00816331011546599,0.0247233961827442,9.96714536742746e-05
CR2,Complement receptor type 2,NMR metabolomics,X23429.Concentration of LDL Particles,39931,0.00536319495429613,0.00424701004736983,-0.00296094473854874,0.013687334647141,0.206673405503596
CR2,Complement receptor type 2,NMR metabolomics,X23430.Concentration of HDL Particles,39931,-0.0638130687589455,0.00435915915611858,-0.0723570207049379,-0.055269116812953,3.24383773724882e-48
CR2,Complement receptor type 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39931,0.0247114698047066,0.00463255084124954,0.0156316701558575,0.0337912694535557,9.72066488528609e-08
CR2,Complement receptor type 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,39931,-0.0312197506184096,0.00422915717562548,-0.0395088986826355,-0.0229306025541836,1.63526123250061e-13
CR2,Complement receptor type 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,39931,-0.0295326172859302,0.0049124288467765,-0.0391609778256121,-0.0199042567462482,1.87424983871228e-09
CR2,Complement receptor type 2,NMR metabolomics,X23434.Phosphoglycerides,39919,-0.0384999649206458,0.0043111186474904,-0.0469497574697269,-0.0300501723715646,4.69702098418092e-19
CR2,Complement receptor type 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39919,0.0394122875371812,0.00464193757452556,0.0303140898911111,0.0485104851832513,2.23564711006561e-17
CR2,Complement receptor type 2,NMR metabolomics,X23436.Total Cholines,39919,-0.0398415375548743,0.00438245059659086,-0.0484311407241924,-0.0312519343855562,1.09226099675469e-19
CR2,Complement receptor type 2,NMR metabolomics,X23437.Phosphatidylcholines,39919,-0.0427709163716095,0.00436966774740814,-0.0513354651565294,-0.0342063675866895,1.46402088870712e-22
CR2,Complement receptor type 2,NMR metabolomics,X23438.Sphingomyelins,39918,-0.0383566878255454,0.00452355746868801,-0.0472228604641739,-0.0294905151869169,2.45985852409483e-17
CR2,Complement receptor type 2,NMR metabolomics,X23439.Apolipoprotein B,39931,0.00560004924470433,0.00426093958982805,-0.00275139235135865,0.0139514908407673,0.188772208243768
CR2,Complement receptor type 2,NMR metabolomics,X23440.Apolipoprotein A1,39931,-0.0626320861631795,0.00449615482136906,-0.0714445496130629,-0.0538196227132962,7.47392137493711e-44
CR2,Complement receptor type 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39931,0.0369653787524872,0.00425638197285542,0.0286228700856906,0.0453078874192838,4.15750702959402e-18
CR2,Complement receptor type 2,NMR metabolomics,X23442.Total Fatty Acids,39919,-0.0106127265770189,0.00414743655546576,-0.0187417022257318,-0.002483750928306,0.0105105619091653
CR2,Complement receptor type 2,NMR metabolomics,X23443.Degree of Unsaturation,39919,-0.00797218489402801,0.00459896378324843,-0.0169861539091949,0.0010417841211389,0.0830306197312669
CR2,Complement receptor type 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,39919,-0.00517563154463088,0.00421996593266743,-0.013446764772659,0.00309550168339729,0.220042520514743
CR2,Complement receptor type 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,39919,-0.0151055226146829,0.00420445132188423,-0.023346247205576,-0.00686479802378984,0.000328190492932167
CR2,Complement receptor type 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39919,-0.0142815602429286,0.00420936708086232,-0.0225319197214187,-0.00603120076443842,0.000693479590947923
CR2,Complement receptor type 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39919,-0.00172264217363745,0.00421957834568954,-0.00999301573118896,0.00654773138391405,0.683095705715658
CR2,Complement receptor type 2,NMR metabolomics,X23448.Saturated Fatty Acids,39919,-0.0150863091789585,0.00416965887147847,-0.0232588405670563,-0.00691377779086069,0.000297666209542566
CR2,Complement receptor type 2,NMR metabolomics,X23449.Linoleic Acid,39919,-0.00775365316585939,0.0042332323002435,-0.0160507884743366,0.000543482142617872,0.0670272647665174
CR2,Complement receptor type 2,NMR metabolomics,X23450.Docosahexaenoic Acid,39919,-0.0213964474932788,0.0044041929974831,-0.0300286657683457,-0.0127642292182119,1.19575241079481e-06
CR2,Complement receptor type 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39919,-0.000466823133677583,0.00426606460539143,-0.00882830976024479,0.00789466349288962,0.912865097063476
CR2,Complement receptor type 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39919,0.00266823544586651,0.0043467575782333,-0.00585140940747077,0.0111878802992038,0.539326446391786
CR2,Complement receptor type 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39919,0.00296634591446277,0.00451902285450689,-0.00589093888037073,0.0118236307092963,0.511567753041321
CR2,Complement receptor type 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39919,0.0194310521074135,0.00461056338422948,0.0103943478743237,0.0284677563405033,2.51740571833769e-05
CR2,Complement receptor type 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39919,-0.021677453576936,0.00415979293376407,-0.0298306477271136,-0.0135242594267584,1.89959787678856e-07
CR2,Complement receptor type 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39919,0.00745598194721165,0.0044480014928728,-0.00126210097881904,0.0161740648732423,0.0937078434285142
CR2,Complement receptor type 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39919,-0.0143256577081141,0.00445647483580741,-0.0230603483862966,-0.00559096702993154,0.0013089753607156
CR2,Complement receptor type 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39919,-0.0105259951492963,0.00461082304038163,-0.0195632083084443,-0.00148878199014825,0.0224499416502517
CR2,Complement receptor type 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39917,-0.000547057715971998,0.00423216069957401,-0.00884209268713705,0.00774797725519305,0.897151927902976
CR2,Complement receptor type 2,NMR metabolomics,X23460.Alanine,39927,0.00508556303318177,0.00410648745118239,-0.00296315237113572,0.0131342784374992,0.21557784446686
CR2,Complement receptor type 2,NMR metabolomics,X23461.Glutamine,39881,0.0101527197535549,0.00406998951793657,0.00217554029839922,0.0181298992087106,0.0126223227749489
CR2,Complement receptor type 2,NMR metabolomics,X23462.Glycine,39912,0.0130921048055453,0.00427220354392255,0.00471858585945714,0.0214656237516335,0.00218406592848052
CR2,Complement receptor type 2,NMR metabolomics,X23463.Histidine,39913,0.0032984259199706,0.00406120492825457,-0.00466153573940835,0.0112583875793496,0.416700891430168
CR2,Complement receptor type 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39920,0.0148625644331462,0.00433535650649941,0.0063652656804074,0.0233598631858851,0.0006090728073923
CR2,Complement receptor type 2,NMR metabolomics,X23465.Isoleucine,39929,0.0107472405701453,0.00422613689218739,0.00246401226145805,0.0190304688788326,0.0109985177056542
CR2,Complement receptor type 2,NMR metabolomics,X23466.Leucine,39930,0.0115696578687867,0.0043598435958151,0.0030243644209891,0.0201149513165843,0.00796961163712654
CR2,Complement receptor type 2,NMR metabolomics,X23467.Valine,39920,0.0164558728789486,0.00431737092405923,0.00799382586779249,0.0249179198901047,0.000138613883019648
CR2,Complement receptor type 2,NMR metabolomics,X23468.Phenylalanine,39927,0.0119343585856872,0.00409856683636188,0.00390116758641792,0.0199675495849565,0.00359804238686585
CR2,Complement receptor type 2,NMR metabolomics,X23469.Tyrosine,39914,0.0214659554397421,0.00418528385363715,0.0132627990866133,0.0296691117928709,2.94812065897162e-07
CR2,Complement receptor type 2,NMR metabolomics,X23470.Glucose,39903,0.0184707065711471,0.00418552676674996,0.0102670741083171,0.026674339033977,1.02615514724472e-05
CR2,Complement receptor type 2,NMR metabolomics,X23471.Lactate,39902,0.00169001347215859,0.00411223669200955,-0.00636997044418013,0.00974999738849731,0.681098674326868
CR2,Complement receptor type 2,NMR metabolomics,X23472.Pyruvate,39877,-0.0150107344087595,0.00407051283366436,-0.0229889395627417,-0.00703252925477739,0.000227059090855616
CR2,Complement receptor type 2,NMR metabolomics,X23473.Citrate,39929,0.0184676413420468,0.00416096544399988,0.0103121490718071,0.0266231336122866,9.12727732257536e-06
CR2,Complement receptor type 2,NMR metabolomics,X23474.3-Hydroxybutyrate,39678,-0.0193341330967398,0.00404172075839204,-0.0272559057831882,-0.0114123604102914,1.73702465704218e-06
CR2,Complement receptor type 2,NMR metabolomics,X23475.Acetate,39917,0.00572545804195545,0.00411418900825283,-0.00233835241422011,0.013789268498131,0.16405159712772
CR2,Complement receptor type 2,NMR metabolomics,X23476.Acetoacetate,39931,-0.0207915367556088,0.00402990890353589,-0.0286901582065391,-0.0128929153046785,2.50814260463742e-07
CR2,Complement receptor type 2,NMR metabolomics,X23477.Acetone,39931,-0.0237496209255452,0.00404816738028294,-0.0316840289908998,-0.0158152128601906,4.53129201114078e-09
CR2,Complement receptor type 2,NMR metabolomics,X23478.Creatinine,39500,0.0219446019208552,0.00508129021300282,0.0119852731033697,0.0319039307383408,1.57912978588793e-05
CR2,Complement receptor type 2,NMR metabolomics,X23479.Albumin,39930,0.0225890038747447,0.00417603621618402,0.014403972891024,0.0307740348584654,6.42132177174607e-08
CR2,Complement receptor type 2,NMR metabolomics,X23480.Glycoprotein Acetyls,39931,0.00415095126651832,0.00437588338313501,-0.0044257801644263,0.0127276826974629,0.342839716330411
CR2,Complement receptor type 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39931,0.024466598314562,0.00438722689485795,0.0158676336006404,0.0330655630284836,2.48958748476194e-08
CR2,Complement receptor type 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39931,0.0258619039612599,0.00440733862054376,0.0172235202649941,0.0345002876575257,4.49978213407175e-09
CR2,Complement receptor type 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39931,0.0247817544446538,0.00441275969377308,0.0161327454448585,0.033430763444449,1.98743469255086e-08
CR2,Complement receptor type 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39931,0.0241964957193954,0.00437758605539654,0.0156164270508182,0.0327765643879727,3.30142680339502e-08
CR2,Complement receptor type 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39931,0.0247397408842199,0.00439495594419102,0.0161256272336055,0.0333538545348343,1.84156352801974e-08
CR2,Complement receptor type 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39931,0.0224339852613786,0.00434275712412294,0.0139221812980976,0.0309457892246595,2.42223829391048e-07
CR2,Complement receptor type 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39931,0.0264962705019024,0.00439967560006138,0.0178729063257821,0.0351196346780227,1.75675232785277e-09
CR2,Complement receptor type 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39931,0.0243966719954679,0.00446611239252401,0.0156430917061209,0.033150252284815,4.76131186366818e-08
CR2,Complement receptor type 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39931,0.0255083626054688,0.00446969740991682,0.0167477556820318,0.0342689695289058,1.1704306837837e-08
CR2,Complement receptor type 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39931,0.0272349551093745,0.00443999054993574,0.0185325736315005,0.0359373365872486,8.76965092550815e-10
CR2,Complement receptor type 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39931,0.0267773338650466,0.00437447888248181,0.0182033552553823,0.0353513124747109,9.49927867126014e-10
CR2,Complement receptor type 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39931,0.0252099853468663,0.00433548684412368,0.0167124311323839,0.0337075395613487,6.18586570832261e-09
CR2,Complement receptor type 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39931,0.0274525202393818,0.00440508231280783,0.0188185589062785,0.0360864815724852,4.71964121149336e-10
CR2,Complement receptor type 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39931,0.023108513382105,0.0045114437912112,0.014266083551331,0.0319509432128789,3.05485851309062e-07
CR2,Complement receptor type 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39931,0.0237216693743943,0.00441761598545447,0.0150631420429036,0.0323801967058851,7.99240303940915e-08
CR2,Complement receptor type 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,39931,0.0235180077791657,0.00442231814352863,0.0148502642178496,0.0321857513404818,1.06302347909668e-07
CR2,Complement receptor type 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,39931,0.025082591983897,0.00444455477486531,0.016371264625161,0.0337939193426331,1.69495611171714e-08
CR2,Complement receptor type 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,39931,0.0256046877131758,0.00434488817018628,0.0170887068996107,0.0341206685267409,3.86689617343258e-09
CR2,Complement receptor type 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39931,0.0253504195620124,0.00427437364525409,0.0169726472173144,0.0337281919067104,3.07659710324167e-09
CR2,Complement receptor type 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39931,0.0251141534023746,0.00442476669515753,0.0164416106798658,0.0337866961248834,1.40412775193843e-08
CR2,Complement receptor type 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,39931,0.0206209039729229,0.00444791019501441,0.0119029999906947,0.0293388079551512,3.57858030133058e-06
CR2,Complement receptor type 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39931,0.0140567643514962,0.00422874960181242,0.0057684151319439,0.0223451135710486,0.000889043805038636
CR2,Complement receptor type 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39931,0.0147388561063036,0.00424405370361834,0.00642051084721162,0.0230572013653955,0.000516365890305033
CR2,Complement receptor type 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39931,0.0130606147807048,0.00422805119716632,0.00477363443425878,0.0213475951271507,0.00201147682391571
CR2,Complement receptor type 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39931,0.00829557606269657,0.00427206743708299,-7.76761139860919e-05,0.0166688282393792,0.0521766282532639
CR2,Complement receptor type 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39931,0.00483423036196187,0.00432363025528773,-0.00364008493840207,0.0133085456623258,0.263543036714303
CR2,Complement receptor type 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39931,0.0121216474931158,0.00422730120591091,0.00383613712953036,0.0204071578567011,0.00414309798809825
CR2,Complement receptor type 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39931,0.0158752809611473,0.00435061006215266,0.00734808523932807,0.0244024766829665,0.000264119063747154
CR2,Complement receptor type 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39931,0.0189174490618165,0.00424447889127145,0.0105982704349244,0.0272366276887085,8.36944559805031e-06
CR2,Complement receptor type 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,39931,0.0165210180256554,0.00423426682318191,0.00822185505221884,0.0248201809990919,9.58919281054233e-05
CR2,Complement receptor type 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,39931,0.0130014588303659,0.0042081382463159,0.00475350786758674,0.0212494097931451,0.00200769185450763
CR2,Complement receptor type 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,39931,0.0158008395162925,0.00421677402811412,0.00753596242118878,0.0240657166113961,0.000179488475519027
CR2,Complement receptor type 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39931,0.0188934159738889,0.00422316257110104,0.0106160173345309,0.027170814613247,7.73832929645601e-06
CR2,Complement receptor type 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39931,0.00984787485725739,0.0042190774864336,0.00157848298384753,0.0181172667306673,0.0196011788718945
CR2,Complement receptor type 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,39931,0.0152326649345257,0.00428740745449811,0.00682934632370945,0.023635983545342,0.000382122785912893
CR2,Complement receptor type 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39931,0.00910197362483088,0.0042404441155184,0.000790703158414814,0.017413244091247,0.0318506574787911
CR2,Complement receptor type 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39931,0.00759926180835905,0.004228412386331,-0.000688426468849703,0.0158869500855678,0.072324178055951
CR2,Complement receptor type 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39931,0.0107929810779297,0.00420214568936738,0.00255677552676964,0.0190291866290898,0.0102245330982207
CR2,Complement receptor type 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39931,0.00246581744422449,0.004387379590134,-0.00613344655243816,0.0110650814408871,0.574106757385175
CR2,Complement receptor type 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39931,-0.000264408617268066,0.00444549373081042,-0.00897757632965648,0.00844875909512035,0.95257220964486
CR2,Complement receptor type 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39931,0.00808367002490208,0.00426044623916766,-0.000266804603866539,0.0164341446536707,0.057796188820627
CR2,Complement receptor type 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39931,0.0101549805594655,0.00416752087907723,0.00198663963647412,0.0183233214824569,0.0148329224276267
CR2,Complement receptor type 2,NMR metabolomics,X23523.Concentration of IDL Particles,39931,-0.00139509608909865,0.00435605817607262,-0.00993297011420099,0.00714277793600369,0.748771074126963
CR2,Complement receptor type 2,NMR metabolomics,X23524.Total Lipids in IDL,39931,-0.0167531659757545,0.00445533131712226,-0.0254856153573141,-0.00802071659419488,0.000170344300427941
CR2,Complement receptor type 2,NMR metabolomics,X23525.Phospholipids in IDL,39931,-0.0114113614111083,0.00445436071744401,-0.0201419084172986,-0.00268081440491806,0.01042095102614
CR2,Complement receptor type 2,NMR metabolomics,X23526.Cholesterol in IDL,39931,-0.019709609558116,0.00448271891105215,-0.0284957386237782,-0.0109234804924538,1.10564749098775e-05
CR2,Complement receptor type 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39931,-0.0216236885111894,0.00447468316600547,-0.0303940675165601,-0.0128533095058187,1.3610714765989e-06
CR2,Complement receptor type 2,NMR metabolomics,X23528.Free Cholesterol in IDL,39931,-0.0136491918768856,0.00448641762433444,-0.0224425704205811,-0.00485581333319008,0.00235128075443668
CR2,Complement receptor type 2,NMR metabolomics,X23529.Triglycerides in IDL,39931,0.00142857421756019,0.00411108447025197,-0.00662915134413367,0.00948629977925405,0.728225318448262
CR2,Complement receptor type 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,39931,0.00139703529394833,0.00425292232090956,-0.00693869245503441,0.00973276304293106,0.742546756446519
CR2,Complement receptor type 2,NMR metabolomics,X23531.Total Lipids in Large LDL,39931,-0.0154628098725749,0.00426956316841372,-0.0238311536826658,-0.00709446606248404,0.000293645228411272
CR2,Complement receptor type 2,NMR metabolomics,X23532.Phospholipids in Large LDL,39931,-0.0138638092044142,0.00428543731409473,-0.0222632663400399,-0.00546435206878857,0.00121846932092587
CR2,Complement receptor type 2,NMR metabolomics,X23533.Cholesterol in Large LDL,39931,-0.016320607835447,0.00427664225537895,-0.0247028266559897,-0.00793838901490427,0.000136019488308522
CR2,Complement receptor type 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39931,-0.0155107762135939,0.00425215503833364,-0.0238450000887278,-0.00717655233845992,0.000265388758808939
CR2,Complement receptor type 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39931,-0.0182556749715555,0.00434955532970628,-0.0267808034177798,-0.00973054652533125,2.71764733586507e-05
CR2,Complement receptor type 2,NMR metabolomics,X23536.Triglycerides in Large LDL,39931,-0.00482016311451355,0.00412357347984846,-0.0129023671350165,0.00326204090598944,0.242449723728642
CR2,Complement receptor type 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39931,0.00948977350671747,0.00422862544994648,0.00120166762482236,0.0177778793886126,0.024834728774232
CR2,Complement receptor type 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,39931,-0.00422015756225741,0.00420783335305656,-0.0124675109342483,0.00402719580973346,0.315910280702571
CR2,Complement receptor type 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,39931,-0.00582838850412144,0.00420029096875471,-0.0140609588028807,0.00240418179463779,0.165273423420327
CR2,Complement receptor type 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,39931,-0.0042092009601691,0.00421009890173558,-0.0124609948075708,0.00404259288723264,0.317428788156011
CR2,Complement receptor type 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39931,-0.00139281978662491,0.00421550908379894,-0.00965521759087083,0.00686957801762101,0.741099255288453
CR2,Complement receptor type 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39931,-0.0115796804492731,0.00421194729749155,-0.0198350971523565,-0.00332426374618965,0.00597992097232611
CR2,Complement receptor type 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,39931,0.000780996800683716,0.00418169353246101,-0.00741512252293987,0.0089771161243073,0.851846720906005
CR2,Complement receptor type 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,39931,0.0144895531914685,0.00424446717879871,0.00617039752102303,0.022808708861914,0.000642332993255638
CR2,Complement receptor type 2,NMR metabolomics,X23545.Total Lipids in Small LDL,39931,0.00164509872098941,0.00423642375883937,-0.00665829184633575,0.00994848928831457,0.69778252255451
CR2,Complement receptor type 2,NMR metabolomics,X23546.Phospholipids in Small LDL,39931,0.00053583012503499,0.00424470679696843,-0.00778379519702313,0.00885545544709311,0.899547567680389
CR2,Complement receptor type 2,NMR metabolomics,X23547.Cholesterol in Small LDL,39931,0.000463766871114466,0.00423161211009512,-0.00783019286467197,0.0087577266069009,0.912731318212565
CR2,Complement receptor type 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39931,0.00262033469718889,0.00423183384571709,-0.00567405964041661,0.0109147290347944,0.535796007116624
CR2,Complement receptor type 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39931,-0.00538549162470048,0.00422489766548923,-0.0136662910490594,0.00289530779965841,0.20243265510624
CR2,Complement receptor type 2,NMR metabolomics,X23550.Triglycerides in Small LDL,39931,0.0115552553310031,0.00423590470345335,0.00325288211223454,0.0198576285497717,0.0063802184666632
CR2,Complement receptor type 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39931,-0.0158878618393634,0.00495208921396375,-0.0255939566987323,-0.00618176697999443,0.00133777032942663
CR2,Complement receptor type 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39931,-0.0159542377231942,0.00496712357570131,-0.0256897999315687,-0.00621867551481961,0.00132089064924492
CR2,Complement receptor type 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39931,-0.0145890468300297,0.00491133408483859,-0.0242152616363133,-0.00496283202374605,0.00297769006257531
CR2,Complement receptor type 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39931,-0.0199927450852313,0.00504121729965612,-0.0298735309925573,-0.0101119591779053,7.3449758722709e-05
CR2,Complement receptor type 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39931,-0.0255307601091537,0.00509969718722434,-0.0355261665961134,-0.015535353622194,5.60652216157657e-07
CR2,Complement receptor type 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39931,-0.00167563314014572,0.00474931838348774,-0.0109842971717817,0.00763303089149025,0.724231389819306
CR2,Complement receptor type 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39931,0.00900443443192077,0.00403185998597465,0.00110198885941046,0.0169068800044311,0.0255415442278516
CR2,Complement receptor type 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,39931,-0.0484289946922559,0.00506023935533203,-0.0583470638287066,-0.0385109255558051,1.21510563098159e-21
CR2,Complement receptor type 2,NMR metabolomics,X23559.Total Lipids in Large HDL,39931,-0.0489927784092142,0.00498480415069763,-0.0587629945445816,-0.0392225622738469,9.84407779043747e-23
CR2,Complement receptor type 2,NMR metabolomics,X23560.Phospholipids in Large HDL,39931,-0.0498146165692611,0.0048803706235463,-0.0593801429914119,-0.0402490901471104,2.1864889661375e-24
CR2,Complement receptor type 2,NMR metabolomics,X23561.Cholesterol in Large HDL,39931,-0.0494170199072711,0.00510261977049231,-0.059418154657436,-0.0394158851571061,4.02797034206894e-22
CR2,Complement receptor type 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39931,-0.0504055638496191,0.00511163775506584,-0.0604243738495482,-0.04038675384969,7.13819199891564e-23
CR2,Complement receptor type 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39931,-0.0444198174636556,0.00503782052874689,-0.0542939456999995,-0.0345456892273117,1.29118520766607e-18
CR2,Complement receptor type 2,NMR metabolomics,X23564.Triglycerides in Large HDL,39931,-0.00380870791784747,0.00407184897270388,-0.0117895319043471,0.00417211606865214,0.34960885404182
CR2,Complement receptor type 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39931,-0.063087741542726,0.00444529677358456,-0.0718005232189518,-0.0543749598665003,1.93148375913508e-45
CR2,Complement receptor type 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,39931,-0.0614455653128737,0.00437433468896517,-0.0700192613032454,-0.0528718693225019,1.4777911609003e-44
CR2,Complement receptor type 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,39931,-0.0577656338980512,0.00430443721780039,-0.06620233084494,-0.0493289369511624,7.65897617357618e-41
CR2,Complement receptor type 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,39931,-0.0683318541089702,0.00450867635187823,-0.0771688597586516,-0.0594948484592889,1.57899759127181e-51
CR2,Complement receptor type 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39931,-0.0689434915788537,0.00449923099760583,-0.0777619843341611,-0.0601249988235462,1.25667116586567e-52
CR2,Complement receptor type 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39931,-0.0635692213700807,0.00452415480394965,-0.072436564785822,-0.0547018779543394,1.39303627994993e-44
CR2,Complement receptor type 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,39931,-0.00243793768811023,0.00411937305687581,-0.0105119088795868,0.00563603350336635,0.55397777530691
CR2,Complement receptor type 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,39931,-0.0465405783884767,0.00406798976538019,-0.0545138383286219,-0.0385673184483315,3.42666861928079e-30
CR2,Complement receptor type 2,NMR metabolomics,X23573.Total Lipids in Small HDL,39931,-0.0466048224966406,0.00408615771886028,-0.0546136916256067,-0.0385959533676744,5.11834624207084e-30
CR2,Complement receptor type 2,NMR metabolomics,X23574.Phospholipids in Small HDL,39931,-0.0478657562893,0.00409184511782222,-0.0558857727202315,-0.0398457398583685,1.75396941747537e-31
CR2,Complement receptor type 2,NMR metabolomics,X23575.Cholesterol in Small HDL,39931,-0.0499398739509062,0.00406149331464542,-0.0579004008476112,-0.0419793470542012,1.36247757984087e-34
CR2,Complement receptor type 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39931,-0.0487786854314061,0.00404848300331538,-0.0567137121179043,-0.040843658744908,2.74385770166434e-33
CR2,Complement receptor type 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39931,-0.0463640396162847,0.00412698477246463,-0.0544529297703154,-0.038275149462254,3.55155942810694e-29
CR2,Complement receptor type 2,NMR metabolomics,X23578.Triglycerides in Small HDL,39931,0.0109500852740186,0.00442880803015738,0.00226962153491017,0.0196305490131271,0.0134286516749302
CR2,Complement receptor type 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39165,-0.00296916152585294,0.00414265544445872,-0.011088766196992,0.00515044314528615,0.473552230531616
CR2,Complement receptor type 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39165,-0.00711325647735517,0.00413918318392348,-0.0152260555178452,0.000999542563134847,0.0857225883594315
CR2,Complement receptor type 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39165,-0.00351916747981206,0.00410315922241102,-0.0115613595557377,0.00452302459611355,0.391086671552249
CR2,Complement receptor type 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39165,-0.0124415786599514,0.00420507351204122,-0.0206835227435522,-0.00419963457635066,0.00309405826499046
CR2,Complement receptor type 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39165,0.00521562918831069,0.00406003802287788,-0.00274204533652996,0.0131733037131513,0.198942555956256
CR2,Complement receptor type 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39738,0.0241432806826098,0.00402531923286814,0.0162536549861883,0.0320329063790314,2.04279053072993e-09
CR2,Complement receptor type 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39738,-0.00340759139470139,0.00449480588235235,-0.012217410924112,0.00540222813470921,0.448391843167062
CR2,Complement receptor type 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39738,-0.00725595034238332,0.00447810764768291,-0.0160330413318418,0.00152114064707518,0.105184229900856
CR2,Complement receptor type 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39738,0.0141577923066337,0.00430236221956839,0.00572516235627961,0.0225904222569877,0.00100155546651938
CR2,Complement receptor type 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39738,-0.00607457481302551,0.00436527907371611,-0.0146305217975091,0.00248137217145807,0.164073294386189
CR2,Complement receptor type 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39927,0.0221577628267604,0.00436508949747893,0.0136021874117017,0.0307133382418191,3.89502416112939e-07
CR2,Complement receptor type 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39927,0.0103671277092417,0.00421138506936936,0.00211281297327777,0.0186214424452057,0.0138388105496623
CR2,Complement receptor type 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39927,0.0071784224450131,0.00439141179627788,-0.00142874467569154,0.0157855895657177,0.102141975077728
CR2,Complement receptor type 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39927,0.0147099977814003,0.00410742417704598,0.0066594463943902,0.0227605491684104,0.000342872698453265
CR2,Complement receptor type 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39927,-0.0164114840110414,0.00404593629994,-0.0243415191589238,-0.00848144886315899,5.00941459219253e-05
CR2,Complement receptor type 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39931,-0.00293860324780551,0.00443065734906905,-0.0116226916519808,0.00574548515636983,0.507184336775107
CR2,Complement receptor type 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39931,-0.00577399981840189,0.00461486666142683,-0.0148191384747985,0.00327113883799469,0.210889322423412
CR2,Complement receptor type 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39931,-0.00669414370334762,0.0046281044479874,-0.0157652284214029,0.00237694101470768,0.14808130785505
CR2,Complement receptor type 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39931,-0.00272942129978408,0.00452904203309132,-0.0116063436846431,0.00614750108507491,0.546750917837341
CR2,Complement receptor type 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39931,0.00525442676899331,0.00458701200377597,-0.00373611675840759,0.0142449702963942,0.25201874492892
CR2,Complement receptor type 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39931,-0.0119358545370831,0.00440468686682768,-0.0205690407960654,-0.00330266827810088,0.00673936177592427
CR2,Complement receptor type 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39931,0.00333288500212416,0.00426419669273902,-0.00502494051564433,0.0116907105198926,0.43446273576143
CR2,Complement receptor type 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39931,0.0131984031417413,0.00414432604222829,0.00507552409897382,0.0213212821845087,0.00145184544400815
CR2,Complement receptor type 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39931,-0.0118053737193708,0.00443810241067434,-0.0205040544442925,-0.00310669299444909,0.00782170797024005
CR2,Complement receptor type 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39931,0.00110515946472008,0.00430873267354297,-0.00733995657542414,0.00955027550486429,0.797573522707449
CR2,Complement receptor type 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39931,0.0285802402669439,0.00429024969328925,0.020171350868097,0.0369891296657909,2.79516068045282e-11
CR2,Complement receptor type 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39931,-0.0113571810744381,0.00452884637567389,-0.0202337199707589,-0.00248064217811728,0.0121602915441115
CR2,Complement receptor type 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39931,-0.0141176541103602,0.00457824675461356,-0.0230910177494028,-0.00514429047131766,0.00204833092493247
CR2,Complement receptor type 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39931,0.00494638740368689,0.00413032190782117,-0.00314904353564261,0.0130418183430164,0.231098559454983
CR2,Complement receptor type 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39931,0.00574730200101678,0.00448706467222122,-0.0030473447565368,0.0145419487585704,0.200261301193499
CR2,Complement receptor type 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39931,0.0337110465214051,0.00413150638406328,0.0256132940086411,0.0418087990341692,3.61087081661856e-16
CR2,Complement receptor type 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39931,-0.0261175720635924,0.00433384226505073,-0.0346119029030919,-0.017623241224093,1.71287491556709e-09
CR2,Complement receptor type 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39931,-0.034272225699041,0.00426986609800908,-0.0426411632511388,-0.0259032881469432,1.07146601089997e-15
CR2,Complement receptor type 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39931,0.00544996170165418,0.00425528958356929,-0.00289040588214164,0.01379032928545,0.200300009535632
CR2,Complement receptor type 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39931,0.0152643090191388,0.00438360309959097,0.0066724469439405,0.0238561710943371,0.000498749941419554
CR2,Complement receptor type 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39931,0.0143021167722851,0.00413811293567892,0.00619141541835439,0.0224128181262157,0.000549278832848643
CR2,Complement receptor type 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39931,-0.0192972680765229,0.0043447472880109,-0.0278129727610243,-0.0107815633920216,8.99230785206407e-06
CR2,Complement receptor type 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39931,-0.0108089274845808,0.00408791631694964,-0.0188212434658021,-0.00279661150335951,0.00819839875860669
CR2,Complement receptor type 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39931,-0.0153274789253642,0.00458741252199083,-0.0243188074684662,-0.00633615038226218,0.000836061347333141
CR2,Complement receptor type 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39931,0.00928430127718756,0.0042518321683535,0.000950710227214694,0.0176178923271604,0.0290060548132814
CR2,Complement receptor type 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39931,-0.0112344719501827,0.00409926180442425,-0.0192690250868542,-0.00319991881351119,0.00613932531017617
CR2,Complement receptor type 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39931,0.000898186319818293,0.00428168130292965,-0.00749390903392381,0.0092902816735604,0.83384656044697
CR2,Complement receptor type 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39931,0.0190841184278706,0.00424105387459259,0.0107716528336692,0.0273965840220721,6.84775869419119e-06
CR2,Complement receptor type 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39931,-0.0208202871406737,0.00444720459125902,-0.0295368081395414,-0.012103766141806,2.86889895802558e-06
CR2,Complement receptor type 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39931,0.00587503471851752,0.00415862621079707,-0.00227587265464473,0.0140259420916798,0.157753168797086
CR2,Complement receptor type 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39931,-0.00477392464969226,0.00419693205602352,-0.0129999114794984,0.00345206218011384,0.255354800867102
CR2,Complement receptor type 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39931,-0.00720948683082129,0.00413553706476952,-0.0153151394777695,0.00089616581612697,0.0813001347989734
CR2,Complement receptor type 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39931,0.00560595210506975,0.00420192358569791,-0.00262981812289816,0.0138417223330377,0.182177056722109
CR2,Complement receptor type 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39931,-0.012604532598112,0.00424064738381186,-0.0209162014703833,-0.00429286372584079,0.00296002879564146
CR2,Complement receptor type 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39931,0.0125631424745001,0.00426662938688679,0.00420054887620203,0.0209257360727982,0.00323927321612855
CR2,Complement receptor type 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39926,-0.0116136313198177,0.00466447281823484,-0.020755998043558,-0.00247126459607741,0.0127913237288249
CR2,Complement receptor type 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39926,-0.00222419711596957,0.0042869209870807,-0.0106265622506477,0.00617816801870859,0.603884180262956
CR2,Complement receptor type 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39926,-0.0277680315820325,0.00408326889626884,-0.0357712386187194,-0.0197648245453456,1.07975180978006e-11
CR2,Complement receptor type 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39926,0.038755479828795,0.00491310797402534,0.0291257881997053,0.0483851714578846,3.26241615213848e-15
CR2,Complement receptor type 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39926,0.0203966422592665,0.00456104378349129,0.0114569964436236,0.0293362880749094,7.80500749735695e-06
CR2,Complement receptor type 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39931,-0.00508321091867327,0.00459436869611789,-0.0140881735630643,0.00392175172571779,0.268569855301755
CR2,Complement receptor type 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39931,-0.016614846359593,0.00468236922891289,-0.0257922900482623,-0.00743740267092376,0.000388707084919453
CR2,Complement receptor type 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39931,-0.0166546231151324,0.00452136426186933,-0.0255164970683963,-0.00779274916186852,0.000230772228241496
CR2,Complement receptor type 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39931,-0.00305537614542625,0.00460604122627865,-0.0120832169489324,0.00597246465807991,0.507121676868464
CR2,Complement receptor type 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39931,0.0340914526805252,0.00442349255125916,0.0254214072800572,0.0427614980809931,1.36405144277264e-14
CR2,Complement receptor type 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39931,0.0403956764433479,0.00461791412854974,0.0313445647513905,0.0494467881353054,2.39211967632189e-18
CR2,Complement receptor type 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39931,-0.0401234048415809,0.00452166363014273,-0.0489858655566606,-0.0312609441265011,7.81589445024454e-19
CR2,Complement receptor type 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39931,-0.0311015678671582,0.00432806077165988,-0.0395845669796116,-0.0226185687547049,6.9632777413187e-13
CR2,Complement receptor type 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39931,-0.0510705183992285,0.00486948125074263,-0.060614701650684,-0.0415263351477729,1.18850786347103e-25
CR2,Complement receptor type 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39931,0.0362273346377986,0.00439545971216683,0.0276122336019516,0.0448424356736456,1.82319710257614e-16
CR2,Complement receptor type 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39931,-0.0148538036126303,0.00412165907231364,-0.0229322553943651,-0.0067753518308956,0.000314496425145909
CR2,Complement receptor type 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39931,-0.0126365299518888,0.00410703384961545,-0.0206863162971351,-0.00458674360664251,0.00209586020229778
CR2,Complement receptor type 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39931,-0.0122864203822957,0.00403154815396656,-0.0201882547640702,-0.00438458600052126,0.00231075252854348
CR2,Complement receptor type 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39931,-0.00121516710651363,0.00446658063157144,-0.00996966514439365,0.0075393309313664,0.785581242717083
CR2,Complement receptor type 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39931,0.0393052759315143,0.00449678687220012,0.0304915736620021,0.0481189782010266,2.54111298246563e-18
CR2,Complement receptor type 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51795,0.00109064107339306,0.00350267514177285,-0.00577460220448172,0.00795588435126785,0.755518835161923
CR2,Complement receptor type 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51795,0.00210060034617516,0.00342671508913351,-0.00461576122852651,0.00881696192087683,0.539876699877111
CR2,Complement receptor type 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49836,0.00328320201641374,0.00326828787479755,-0.00312264221818946,0.00968904625101695,0.315116539414849
CR2,Complement receptor type 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49836,0.000623573038987483,0.00352966338377627,-0.006294567193214,0.00754171327118896,0.859771786139502
CR2,Complement receptor type 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49836,-0.000266143765950044,0.00351128391974316,-0.00714826024864664,0.00661597271674655,0.939581418035114
CR2,Complement receptor type 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49836,0.00107093430219695,0.0032413289005491,-0.00528207034287928,0.00742393894727318,0.741100584828245
CR2,Complement receptor type 2,Working and living environment,X24009.Traffic intensity on the nearest road,51795,-0.0551946809082528,0.0477399907770456,-0.148765062831262,0.0383757010147567,0.24762891929102
CR2,Complement receptor type 2,Working and living environment,X24010.Inverse distance to the nearest road,51795,0.00132645755170623,0.00305909674100766,-0.00466937206066878,0.00732228716408124,0.664574399541282
CR2,Complement receptor type 2,Working and living environment,X24011.Traffic intensity on the nearest major road,51795,0.00341373749825255,0.00309351042351667,-0.00264954293184011,0.00947701792834522,0.269812758209395
CR2,Complement receptor type 2,Working and living environment,X24012.Inverse distance to the nearest major road,51795,-0.00201604926954353,0.00313528470723064,-0.00816120729571559,0.00412910875662852,0.520216711345688
CR2,Complement receptor type 2,Working and living environment,X24013.Total traffic load on major roads,51795,-0.00138263825963454,0.0330627441899692,-0.0661856168719743,0.0634203403527052,0.966643592088614
CR2,Complement receptor type 2,Working and living environment,X24015.Sum of road length of major roads within 100m,51795,-0.0145382464610902,0.0321286232446167,-0.0775103480205389,0.0484338550983585,0.650911338945818
CR2,Complement receptor type 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51795,0.000858895524046689,0.00351668325865869,-0.00603380366292435,0.00775159471101773,0.807050970189535
CR2,Complement receptor type 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51795,0.00031753690835798,0.00351541889281209,-0.00657268412155371,0.00720775793826967,0.92802808803605
CR2,Complement receptor type 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51795,0.00215048879232052,0.00348046506268209,-0.00467122273053637,0.00897220031517741,0.53666345061516
CR2,Complement receptor type 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51746,0.00274120705180956,0.00337582717024692,-0.00387541420187441,0.00935782830549352,0.416792547474655
CR2,Complement receptor type 2,Working and living environment,X24020.Average daytime sound level of noise pollution,51795,-0.00210063787345107,0.00306999818317089,-0.00811783431246601,0.00391655856556387,0.49382471435397
CR2,Complement receptor type 2,Working and living environment,X24021.Average evening sound level of noise pollution,51795,-0.00208261391655916,0.0030693821101135,-0.00809860285238162,0.0039333750192633,0.497452465424518
CR2,Complement receptor type 2,Working and living environment,X24022.Average night-time sound level of noise pollution,51795,-0.00210159470544046,0.00307003131858522,-0.00811885608986749,0.00391566667898657,0.493632626838115
CR2,Complement receptor type 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51795,-0.00204995173804106,0.0030696481116413,-0.00806646203685801,0.00396655856077588,0.504258312930827
CR2,Complement receptor type 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51795,-0.00204785494068517,0.0030697180198236,-0.00806450225953943,0.0039687923781691,0.504704188952996
CR2,Complement receptor type 2,Health and medical history,X2405.Number of children fathered,36343,-0.0661849210923895,0.0360661574561308,-0.136874589706406,0.00450474752162677,0.0665150004799486
CR2,Complement receptor type 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48613,0.00172959339199641,0.00362349676825567,-0.0053724602737847,0.00883164705777752,0.633133393792368
CR2,Complement receptor type 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48613,0.00119273169731483,0.00330762080700897,-0.00529020508442274,0.00767566847905241,0.71840074484536
CR2,Complement receptor type 2,Working and living environment,"X24502.Water percentage, buffer 1000m",48613,-0.00319465825822393,0.00323683604996946,-0.00953885691616407,0.00314954039971621,0.323667268258776
CR2,Complement receptor type 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48613,0.000856958244900067,0.00342589880254639,-0.00585780340809086,0.007571719897891,0.802480274867931
CR2,Complement receptor type 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48613,0.000980680373001586,0.00334826400878642,-0.0055819170842198,0.00754327783022297,0.769607015009463
CR2,Complement receptor type 2,Working and living environment,"X24505.Water percentage, buffer 300m",48613,-0.00110270439275826,0.00324604239507776,-0.00746494748711067,0.00525953870159415,0.734079823914029
CR2,Complement receptor type 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51883,-0.00213615582388467,0.00345714371659106,-0.00891215750840314,0.0046398458606338,0.536648812329417
CR2,Complement receptor type 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51883,-0.00513217542855871,0.00326238218366856,-0.0115264445085491,0.00126209365143168,0.115698295703283
CR2,Complement receptor type 2,Working and living environment,X24508.Distance (Euclidean) to coast,51883,-0.00217664341453251,0.00311921700835832,-0.00829030875091481,0.0039370219218498,0.485297283680839
CR2,Complement receptor type 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,28700,-0.00857517601944827,0.0547626223365936,-0.115909915799172,0.0987595637602753,0.875575997721362
CR2,Complement receptor type 2,Health and medical history,X2704.Years since last cervical smear test,35668,-0.0144517127284149,0.0334422510211131,-0.0799985247297965,0.0510950992729667,0.665648025126335
CR2,Complement receptor type 2,Health and medical history,X2714.Age when periods started (menarche),39040,-0.0484566930529919,0.029514343766792,-0.106304806835904,0.0093914207299205,0.100651868490423
CR2,Complement receptor type 2,Health and medical history,X2734.Number of live births,39518,-0.0556410110102578,0.0282907428404976,-0.111090866977633,-0.000191155042882515,0.0492288948913437
CR2,Complement receptor type 2,Health and medical history,X2744.Birth weight of first child,35608,-0.0474597260010775,0.0325969539264197,-0.11134975569686,0.0164303036947052,0.145431563319109
CR2,Complement receptor type 2,Health and medical history,X2754.Age at first live birth,33599,0.0109736282086261,0.00519959387364611,0.00078242421627967,0.0211648322009724,0.0348426336925842
CR2,Complement receptor type 2,Health and medical history,X2764.Age at last live birth,33575,0.00274493510222143,0.00520674001030023,-0.00746027531796702,0.0129501455224099,0.598074510999705
CR2,Complement receptor type 2,Health and medical history,X2794.Age started oral contraceptive pill,37231,0.0288489474796968,0.00515135071286927,0.018752300082473,0.0389455948769206,2.18238163575531e-08
CR2,Complement receptor type 2,Health and medical history,X2804.Age when last used oral contraceptive pill,36035,-0.00459082897401228,0.00455839909378253,-0.013525291197826,0.00434363324980148,0.313899856768865
CR2,Complement receptor type 2,Lifestyle factors,X2867.Age started smoking in former smokers,29355,0.00282606494397669,0.00695103105296554,-0.0107979559198358,0.0164500858077891,0.684341332953446
CR2,Complement receptor type 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36574,0.0369318895991414,0.0390895902441205,-0.0396837072793348,0.113547486477618,0.344778364423527
CR2,Complement receptor type 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36568,0.0440598630709161,0.0433516111842395,-0.0409092948501934,0.129029020992026,0.309488104461695
CR2,Complement receptor type 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36590,0.0035401433791054,0.0447685147374188,-0.0842061455062354,0.0912864322644462,0.936972913131642
CR2,Complement receptor type 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36560,0.0392457811881935,0.0434315702576573,-0.0458800965168148,0.124371658893202,0.366212295294549
CR2,Complement receptor type 2,Mental health,X28739.Difficulty with standing for long periods,36600,0.0723076868005329,0.0407508174105612,-0.0075639153241671,0.152179288925233,0.0760231780802464
CR2,Complement receptor type 2,Mental health,X28740.Difficulty with taking care of household responsibilities,36624,0.0560630352051629,0.0454986086764592,-0.0331142378006972,0.145240308211023,0.217899962212936
CR2,Complement receptor type 2,Mental health,X28741.Difficulty learning a new task,36529,0.0861360536237048,0.0510817779332389,-0.0139842311254433,0.186256338372853,0.0917745259096742
CR2,Complement receptor type 2,Mental health,X28742.Difficulty with joining in community activities,36090,-0.0107863623378716,0.0493950491596592,-0.107600658690804,0.0860279340150604,0.827145027308487
CR2,Complement receptor type 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,36537,0.0153205279964692,0.0422876140858452,-0.0675631956117875,0.0982042516047258,0.717138750603494
CR2,Complement receptor type 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36622,-0.00958381989857,0.0577554609909259,-0.122784523440785,0.103616883643645,0.868208450408084
CR2,Complement receptor type 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29200,0.0398762570916193,0.0519462377096331,-0.0619383688192615,0.1416908830025,0.442732210851851
CR2,Complement receptor type 2,Lifestyle factors,X2897.Age stopped smoking,29360,0.017177992349493,0.00838061947920918,0.000751978170243011,0.033604006528743,0.0404382801481745
CR2,Complement receptor type 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35236,0.0016825828838389,0.00976440163682909,-0.0174556443243461,0.0208208100920239,0.863190541211845
CR2,Complement receptor type 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35236,-0.00266780396152531,0.0104896844613971,-0.0232275855058637,0.017891977582813,0.799247982397275
CR2,Complement receptor type 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35236,-0.0309457282492948,0.0354986196024027,-0.100523022670004,0.0386315661714144,0.38336614660361
CR2,Complement receptor type 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35236,-0.0117163324296574,0.0345606514635767,-0.0794552092982678,0.056022544438953,0.734610067650235
CR2,Complement receptor type 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35236,0.0275520553669681,0.0376372436242242,-0.0462169421365114,0.101321052870448,0.464157814368845
CR2,Complement receptor type 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35236,0.00177748485493784,0.0318304730542147,-0.060610242331323,0.0641652120411987,0.955468466959458
CR2,Complement receptor type 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35236,-0.0104707931674009,0.0145350301938316,-0.0389594523473108,0.0180178660125091,0.471303824331222
CR2,Complement receptor type 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35236,0.0177559567332832,0.0266516515576243,-0.0344812803196603,0.0699931937862267,0.505281760369834
CR2,Complement receptor type 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35163,-0.00894457975699389,0.0450817691761264,-0.0973048473422016,0.0794156878282138,0.842729495405327
CR2,Complement receptor type 2,Mental health,X29003.Recent feelings of depression,35157,0.0310677121892608,0.0435755400071704,-0.0543403462247932,0.116475770603315,0.475883886438261
CR2,Complement receptor type 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35168,0.0401849121520477,0.0357609599640224,-0.0299065693774362,0.110276393681531,0.26116036076969
CR2,Complement receptor type 2,Mental health,X29005.Recent feelings of tiredness or low energy,35174,0.0738632413133145,0.0362389782511724,0.00283484394101659,0.144891638685612,0.0415505091761022
CR2,Complement receptor type 2,Mental health,X29006.Recent poor appetite or overeating,35176,0.068441572978765,0.0479770863319018,-0.0255935162317626,0.162476662189293,0.153738077088237
CR2,Complement receptor type 2,Mental health,X29007.Recent feelings of inadequacy,35142,0.0382310029161903,0.0466598469072432,-0.0532222970220064,0.129684302854387,0.412600918201763
CR2,Complement receptor type 2,Mental health,X29008.Recent trouble concentrating on things,35174,0.0248197378130429,0.0464671402435275,-0.066255857064271,0.115895332690357,0.593258455909027
CR2,Complement receptor type 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35165,0.0707480679579493,0.0829079584936911,-0.0917515306896852,0.233247666605584,0.393492941341906
CR2,Complement receptor type 2,Mental health,X29010.Recent thoughts of suicide or self-harm,35101,0.0689802434732045,0.0911367106257734,-0.109647709353311,0.24760819629972,0.449133088847775
CR2,Complement receptor type 2,Mental health,X29038#0.Substances taken for depression_None of options listed,32754,0.0413066340194236,0.0190364852065403,0.00399512301460455,0.0786181450242427,0.0300433368015172
CR2,Complement receptor type 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32754,-0.065241250632274,0.0338733333364555,-0.131632983971727,0.00115048270717889,0.0541317471554906
CR2,Complement receptor type 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32754,-0.0283809737513837,0.0186185364481389,-0.0648733051897359,0.00811135768696855,0.127459436616915
CR2,Complement receptor type 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32754,0.00838004111144244,0.0536547786773581,-0.0967833250961794,0.113543407319064,0.87589119264438
CR2,Complement receptor type 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32754,-0.0166513391553081,0.0320449866489993,-0.0794595129873468,0.0461568346767305,0.603338706789455
CR2,Complement receptor type 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32754,-0.0551642367157415,0.0344672023323949,-0.122719953287235,0.0123914798557525,0.109526571906688
CR2,Complement receptor type 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32754,0.0298947463108854,0.0389633067021953,-0.0464733348254174,0.106262827447188,0.442950979753952
CR2,Complement receptor type 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32754,0.0206153628337195,0.0482372545305716,-0.0739296560462009,0.11516038171364,0.669117070221676
CR2,Complement receptor type 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32754,-0.0366111640042454,0.0376873335889231,-0.110478337838535,0.0372560098300438,0.331353249475878
CR2,Complement receptor type 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32754,0.00745519239136377,0.0192705752196368,-0.0303151350391244,0.0452255198218519,0.698862285416129
CR2,Complement receptor type 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32754,0.0287471553895115,0.0280597084675443,-0.0262498732068754,0.0837441839858984,0.305627302305296
CR2,Complement receptor type 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32754,-0.0220312598323205,0.04408739878185,-0.108442561444746,0.0643800417801055,0.617286128645965
CR2,Complement receptor type 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32754,-0.0795676873163892,0.0557824017638538,-0.188901194773543,0.0297658201407643,0.15378972307701
CR2,Complement receptor type 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32754,-0.0815196440137237,0.0336154081481974,-0.147405843984191,-0.0156334440432568,0.0153253076612016
CR2,Complement receptor type 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32754,-0.0352273475877669,0.0571322776893874,-0.147206611858966,0.0767519166834325,0.537519166710865
CR2,Complement receptor type 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32754,-0.00139195232058036,0.0545375776184218,-0.108285604452687,0.105501699811526,0.979638525952851
CR2,Complement receptor type 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32754,-0.0470388316130835,0.0292570903794027,-0.104382728756713,0.0103050655305458,0.107919862684443
CR2,Complement receptor type 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32754,-0.00961215098019176,0.02863284823562,-0.065732533522007,0.0465082315616235,0.737102289479197
CR2,Complement receptor type 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32754,-0.0387428021063926,0.0412110133442735,-0.119516388261169,0.0420307840483834,0.347187712030947
CR2,Complement receptor type 2,Mental health,X29058.Recent feelings or nervousness or anxiety,34998,0.130898789672189,0.0415122619527861,0.0495347562447284,0.21226282309965,0.00161888955769882
CR2,Complement receptor type 2,Mental health,X29059.Recent inability to stop or control worrying,35003,0.0694141248301043,0.0435392872710186,-0.015922878221092,0.154751127881301,0.110900107770671
CR2,Complement receptor type 2,Mental health,X29060.Recent worrying too much about different things,34996,0.0806416776217915,0.0400121351023368,0.00221789282121136,0.159065462422372,0.0438835432898394
CR2,Complement receptor type 2,Mental health,X29061.Recent trouble relaxing,35002,0.0510012277867952,0.0418833580314339,-0.0310901539548152,0.133092609528406,0.223365034856045
CR2,Complement receptor type 2,Mental health,X29062.Recent restlessness,35006,-0.0268799142921592,0.0587787062572234,-0.142086178556317,0.0883263499719988,0.647459307892812
CR2,Complement receptor type 2,Mental health,X29063.Recent easy annoyance or irritability,34988,0.102075819741745,0.0424563412357084,0.0188613909197562,0.185290248563733,0.0162217602923879
CR2,Complement receptor type 2,Mental health,X29064.Recent feelings of foreboding,34980,0.023608314023533,0.0484764650391587,-0.0714055574532181,0.118622185500284,0.62626390365111
CR2,Complement receptor type 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32754,0.0086161217512142,0.0192545971558614,-0.0291228886742741,0.0463551321767025,0.654536625623323
CR2,Complement receptor type 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32754,0.0141418582678288,0.0316282749852923,-0.0478495607033441,0.0761332772390017,0.65479419492981
CR2,Complement receptor type 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32754,0.0094524192033616,0.0409081200539961,-0.0707274961024708,0.0896323345091941,0.817269915799828
CR2,Complement receptor type 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32754,0.0579068023003687,0.0457825777743411,-0.0318270501373399,0.147640654738077,0.205968355527173
CR2,Complement receptor type 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,32754,-0.00568084649827178,0.0287645312357508,-0.0620593277203433,0.0506976347237997,0.843444832046517
CR2,Complement receptor type 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32754,-0.0342003271094375,0.0310473377370101,-0.0950531090739773,0.0266524548551024,0.270685312499597
CR2,Complement receptor type 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32754,0.0175602682835634,0.0311618834822431,-0.043517023341633,0.0786375599087598,0.573096718602806
CR2,Complement receptor type 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32754,0.0154651677760303,0.0281765587978428,-0.0397608874677415,0.0706912230198022,0.583110882473361
CR2,Complement receptor type 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32754,0.0564192475266677,0.037860626043687,-0.0177875795189588,0.130626074572294,0.136211681467758
CR2,Complement receptor type 2,Mental health,X29076.Felt loved as a child,34954,-0.0289818215650306,0.0373137003738372,-0.102116674297751,0.0441530311676903,0.437348073182528
CR2,Complement receptor type 2,Mental health,X29077.Physically abused by family as a child,34958,0.00807884330341513,0.0481188241583805,-0.0862340520470106,0.102391738653841,0.866670033962921
CR2,Complement receptor type 2,Mental health,X29078.Felt hated by family member as a child,34944,-0.0283925574692685,0.0491204887614838,-0.124668715441777,0.0678836005032397,0.563263289109657
CR2,Complement receptor type 2,Mental health,X29079.Sexually molested as a child,34863,-0.0392732468617398,0.0667573193057586,-0.170117592701027,0.091571098977547,0.556343869059092
CR2,Complement receptor type 2,Mental health,X29080.Someone to take to doctor when needed as a child,34942,-0.0534569358351261,0.0558805049571579,-0.162982725551156,0.0560688538809035,0.338775200290707
CR2,Complement receptor type 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34944,-0.0982497650756748,0.0662248952084675,-0.228050559684271,0.0315510295329215,0.137949475770531
CR2,Complement receptor type 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34883,-0.0180778432720738,0.0526074922817194,-0.121188528144244,0.0850328416000962,0.731126386908833
CR2,Complement receptor type 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34951,-0.0651645405236975,0.0582554349353568,-0.179345192996997,0.0490161119496018,0.263334971589311
CR2,Complement receptor type 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34914,-0.141724474181127,0.0813840401629157,-0.301237192900442,0.0177882445381874,0.0816363447428909
CR2,Complement receptor type 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34914,-0.0287717004130968,0.0792994976887918,-0.184198715883129,0.126655315056935,0.716743870350808
CR2,Complement receptor type 2,Mental health,X29086.Experienced a violent or sexual assault,34950,-0.0772417064502441,0.0642161170793662,-0.203105295925802,0.0486218830253136,0.229063970702065
CR2,Complement receptor type 2,Mental health,X29087.Experienced a life-threatening injury or illness,34958,-0.0174039678935448,0.0452007373794846,-0.105997413157335,0.0711894773702451,0.700217192415157
CR2,Complement receptor type 2,Mental health,X29088.Experienced a marital separation or divorce,34959,-0.107441419094471,0.0403175834798811,-0.186463882715038,-0.0284189554739042,0.00771277952154384
CR2,Complement receptor type 2,Mental health,X29089.Experienced the death of a spouse or partner,34972,0.0727470253308753,0.0641453827117364,-0.052977924784128,0.198471975445879,0.256778726555334
CR2,Complement receptor type 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34956,0.00928876969378973,0.0499396146545643,-0.0885928750291564,0.107170414416736,0.852448140161023
CR2,Complement receptor type 2,Lifestyle factors,X29091.Frequency of drinking alcohol,34966,-0.284158539428174,0.0339615014642881,-0.350723082298178,-0.217593996558169,6.61315858257624e-17
CR2,Complement receptor type 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33852,-0.220795661054765,0.0380314077990075,-0.29533722034082,-0.14625410176871,6.60858954479536e-09
CR2,Complement receptor type 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33866,-0.286456256454877,0.0382250504130929,-0.361377355264539,-0.211535157645215,7.24971995131737e-14
CR2,Complement receptor type 2,Mental health,X29104.Ever used cannabis,34952,-0.0738922973740811,0.044584416892881,-0.161277754484128,0.0134931597359658,0.0974755984363818
CR2,Complement receptor type 2,Mental health,X29108.Ever thought that life not worth living,34906,0.0410127899007529,0.041136942926152,-0.039615618234505,0.121641198036011,0.318795108538333
CR2,Complement receptor type 2,Mental health,X29109.Ever contemplated self-harm,34926,0.0218477448283572,0.0537128265332545,-0.0834293951768216,0.127124884833536,0.684198760593004
CR2,Complement receptor type 2,Mental health,X29111.Ever self-harmed,34943,0.0342755689134382,0.0839740613361219,-0.130313591305361,0.198864729132237,0.683157838554911
CR2,Complement receptor type 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34947,-0.0279348834970113,0.0579403802507306,-0.141498028788443,0.0856282617944207,0.629722039411995
CR2,Complement receptor type 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33450,0.0231913864520661,0.0397875348096767,-0.0547921817749003,0.101174954679033,0.559987313744118
CR2,Complement receptor type 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33450,-0.00443842776498025,0.0309518456319159,-0.0651040452035353,0.0562271896735748,0.885979002682876
CR2,Complement receptor type 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33450,0.000472175903368048,0.0323628749594994,-0.0629590590172507,0.0639034108239868,0.988359542348976
CR2,Complement receptor type 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33450,0.0606402331865242,0.0430825898054252,-0.0238016428321091,0.145082109205158,0.159301353877084
CR2,Complement receptor type 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34939,-0.0702281558026643,0.0378665552206032,-0.144446604035047,0.00399029242971792,0.0636767422237923
CR2,Complement receptor type 2,Health and medical history,X29153.Pain or discomfort today,34954,-0.00760650628483584,0.0362724643267163,-0.0787005363651998,0.0634875237955281,0.833902007990591
CR2,Complement receptor type 2,Mental health,X29154.Anxiety or depression today,34954,0.122734881056009,0.0447039346542939,0.0351151691335932,0.210354592978425,0.00605151520502621
CR2,Complement receptor type 2,Mental health,X29166.Frequency of confiding in someone close,34718,-0.00444381971644453,0.0355923455468941,-0.074204816988357,0.0653171775554679,0.900642048603
CR2,Complement receptor type 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34919,0.0146631803139927,0.010145249680805,-0.00522150906038515,0.0345478696883705,0.148395027931827
CR2,Complement receptor type 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34919,-0.0341918772489259,0.0100781509268608,-0.0539450530655732,-0.0144387014322787,0.000694567169297786
CR2,Complement receptor type 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34919,-0.0448668640181887,0.0125250674937952,-0.0694159963060272,-0.0203177317303502,0.000342221329518008
CR2,Complement receptor type 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34919,0.0494911249702754,0.0149505005429723,0.0201881439060498,0.078794106034501,0.00093483503668537
CR2,Complement receptor type 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34919,-0.0449578238319443,0.0232459238563596,-0.090519834590409,0.000604186926520478,0.0531375145510349
CR2,Complement receptor type 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34919,0.00355142302095585,0.0109163299403405,-0.0178445836621115,0.0249474297040232,0.744936553484288
CR2,Complement receptor type 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34918,0.012509850819974,0.0119511564997755,-0.0109144159195861,0.035934117559534,0.295238634185332
CR2,Complement receptor type 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34918,-0.0285549133436476,0.0169218475873531,-0.0617217346148596,0.00461190792756445,0.091543450639483
CR2,Complement receptor type 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34918,-0.052522474554881,0.0272174716614877,-0.105868719011397,0.000823769901634963,0.0536653813306233
CR2,Complement receptor type 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34918,0.056067747583629,0.0268927415970222,0.00335797405346541,0.108777521113793,0.0371044000649823
CR2,Complement receptor type 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34918,-0.0762843804134225,0.0356776866801339,-0.146212646306485,-0.00635611452036006,0.0325261187953957
CR2,Complement receptor type 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34918,0.00450169230600859,0.0179254009107663,-0.0306320934790934,0.0396354780911106,0.801714543246504
CR2,Complement receptor type 2,Mental health,X29171.Frequency of feeling 'in tune' with people,34731,-0.0484372744921469,0.043197155642713,-0.133103699551864,0.0362291505675706,0.262181962715132
CR2,Complement receptor type 2,Mental health,X29172.Freuency of feeling that lacks companionship,34872,0.0508612091476856,0.0395991682718438,-0.0267531606651283,0.1284755789605,0.199028724229675
CR2,Complement receptor type 2,Mental health,X29173.Frequency of feeling left out,34823,0.0538436723099295,0.0407353715839351,-0.0259976559945834,0.133685000614442,0.186265136321933
CR2,Complement receptor type 2,Mental health,X29174.Frequency of feeling isolated from others,34856,0.00438754073097048,0.0420054801330261,-0.0779432003297607,0.0867182817917016,0.916812859696767
CR2,Complement receptor type 2,Mental health,X29175.Tendency to bounce back quickly after hard times,34937,-0.061873409934159,0.0355677477199947,-0.131586195465349,0.00783937559703062,0.08195826836637
CR2,Complement receptor type 2,Mental health,X29176.Ability to make it through stressful events,34937,0.0680125375864603,0.0348161650847229,-0.000227145979596582,0.136252221152517,0.0507883809520769
CR2,Complement receptor type 2,Mental health,X29177.Quick recovery from stressful events,34937,-0.0593605000411137,0.0350988735244541,-0.128154292149044,0.00943329206681626,0.0908197586378928
CR2,Complement receptor type 2,Mental health,X29178.Hard to snap back when something bad happens,34937,0.0739025017209255,0.03481001315627,0.00567487593463628,0.142130127507215,0.0337739395308381
CR2,Complement receptor type 2,Mental health,X29179.Comes through difficult times with little trouble,34937,-0.0442964400227725,0.0349881232379378,-0.112873161569131,0.0242802815235857,0.205524611542452
CR2,Complement receptor type 2,Mental health,X29180.Tendency to take a long time to get over setbacks,34937,0.0750993254958733,0.0349120925967879,0.006671624006169,0.143527026985578,0.0314900476544233
CR2,Complement receptor type 2,Mental health,X29181.General happiness,34868,0.0264838822959265,0.0361393757538795,-0.0443492941816773,0.0973170587735304,0.463680033866211
CR2,Complement receptor type 2,Mental health,X29182.Belief that own life is meaningful,34765,-0.0132400226200551,0.0358441680688249,-0.0834945920349519,0.0570145467948416,0.711853676999652
CR2,Complement receptor type 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28892,0.0646092545068726,0.0503338743406872,-0.0340451392008742,0.163263648214619,0.199336244410236
CR2,Complement receptor type 2,Health and medical history,X2946.Father's age,34115,-0.01073275683766,0.00736394577585962,-0.0251660905583449,0.00370057688302482,0.145016303421165
CR2,Complement receptor type 2,Health and medical history,X2966.Age high blood pressure diagnosed,29061,-0.00390655622334855,0.0123720754522442,-0.0281558241097471,0.02034271166305,0.752200438182892
CR2,Complement receptor type 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51303,-0.00242672967996102,0.00321538761445917,-0.00872888940430099,0.00387543004437895,0.450421176934208
CR2,Complement receptor type 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51303,0.0785867957609667,0.00377055818315853,0.071196501721976,0.0859770897999574,9.90490716519529e-96
CR2,Complement receptor type 2,Blood and urine assays,X30020.Haemoglobin concentration,51303,0.0371028052887782,0.00404291095110653,0.0291786998246094,0.045026910752947,4.72417553595039e-20
CR2,Complement receptor type 2,Blood and urine assays,X30030.Haematocrit percentage,51303,0.036781658544144,0.00396053616892027,0.0290190076530603,0.0445443094352277,1.7000247149977e-20
CR2,Complement receptor type 2,Blood and urine assays,X30040.Mean corpuscular volume,51303,-0.0627246804895879,0.00319477657525747,-0.0689864425770925,-0.0564629184020833,3.07961645356378e-85
CR2,Complement receptor type 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51302,-0.0559662194052645,0.00320748170763966,-0.0622528835522382,-0.0496795552582908,8.19540945482641e-68
CR2,Complement receptor type 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51302,-0.00215623888874325,0.00314533902435449,-0.00832110337647806,0.00400862559899155,0.493012393822026
CR2,Complement receptor type 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51303,0.000269867704717261,0.00306538775170637,-0.00573829228862722,0.00627802769806174,0.929847868595067
CR2,Complement receptor type 2,Blood and urine assays,X30080.Platelet count,51303,-0.0342045154066089,0.00323763825651386,-0.0405502863893761,-0.0278587444238418,4.87646599072437e-26
CR2,Complement receptor type 2,Blood and urine assays,X30090.Platelet crit,51303,-0.0296564164407552,0.00331829788850314,-0.0361602803022214,-0.0231525525792891,4.23461847425728e-19
CR2,Complement receptor type 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51303,0.0172429376844791,0.00312551171254962,0.0111169347278819,0.0233689406410764,3.48269133680406e-08
CR2,Complement receptor type 2,Blood and urine assays,X30110.Platelet distribution width,51303,0.0291347376156122,0.00308972118190143,0.0230788840990854,0.035190591132139,4.43175214760997e-21
CR2,Complement receptor type 2,Blood and urine assays,X30120.Lymphocyte count,51266,0.00795820457250618,0.00327557556901954,0.00153807645722788,0.0143783326877845,0.0151235786919288
CR2,Complement receptor type 2,Blood and urine assays,X30130.Monocyte count,51266,-0.00380710354958706,0.00326643739287653,-0.0102093208396251,0.00259511374045093,0.243818039350188
CR2,Complement receptor type 2,Blood and urine assays,X30140.Neutrophill count,51266,-0.00741688396058754,0.00318570981853864,-0.0136608752049233,-0.0011728927162518,0.0199101509221862
CR2,Complement receptor type 2,Blood and urine assays,X30150.Eosinophill count,51266,0.0303245279685025,0.00312282054022625,0.0242037997096591,0.036445256227346,2.95079294193271e-22
CR2,Complement receptor type 2,Blood and urine assays,X30160.Basophill count,51266,-0.0279406471440746,0.0241430855799205,-0.0752610948807187,0.0193798005925696,0.247162366652263
CR2,Complement receptor type 2,Blood and urine assays,X30170.Nucleated red blood cell count,51266,0.163789488676335,0.105621325271147,-0.0432283088551127,0.370807286207782,0.120979468023479
CR2,Complement receptor type 2,Blood and urine assays,X30180.Lymphocyte percentage,51266,0.0103387426537114,0.00321799458584544,0.00403147326545434,0.0166460120419685,0.00131604016004102
CR2,Complement receptor type 2,Blood and urine assays,X30190.Monocyte percentage,51266,-0.00367079635374647,0.00322412026762476,-0.009990072078291,0.00264847937079806,0.254904181673937
CR2,Complement receptor type 2,Blood and urine assays,X30200.Neutrophill percentage,51266,-0.0126867582958364,0.00316932218410171,-0.0188986297766758,-0.00647488681499709,6.27120714324478e-05
CR2,Complement receptor type 2,Blood and urine assays,X30210.Eosinophill percentage,51266,0.0315500277616948,0.00308314014013001,0.02550707308704,0.0375929824363497,1.56045178372907e-24
CR2,Complement receptor type 2,Blood and urine assays,X30220.Basophill percentage,51266,-0.00573351586939354,0.00306910720853778,-0.0117489659981276,0.00028193425934052,0.061753497434975
CR2,Complement receptor type 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51265,0.15841074745129,0.105803378898064,-0.0489638751889149,0.365785370091494,0.134348001097558
CR2,Complement receptor type 2,Blood and urine assays,X30240.Reticulocyte percentage,50815,0.00751809498248339,0.00329534089201225,0.00105922683413938,0.0139769631308274,0.0225306793825759
CR2,Complement receptor type 2,Blood and urine assays,X30250.Reticulocyte count,50815,0.0217992556111885,0.00337676944511986,0.0151807874987536,0.0284177237236235,1.09584212310382e-10
CR2,Complement receptor type 2,Blood and urine assays,X30260.Mean reticulocyte volume,50815,-0.0301007627390578,0.00318892684305782,-0.0363510593514511,-0.0238504661266644,4.05123794266829e-21
CR2,Complement receptor type 2,Blood and urine assays,X30270.Mean sphered cell volume,50815,-0.0556323344962385,0.00318945210730873,-0.0618836606265636,-0.0493810083659134,9.23863953045656e-68
CR2,Complement receptor type 2,Blood and urine assays,X30280.Immature reticulocyte fraction,50815,-0.00995911732311758,0.00332753640727667,-0.0164810886813799,-0.00343714596485531,0.00276554227026015
CR2,Complement receptor type 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50815,0.000931478994277822,0.00337178116521926,-0.00567721208955192,0.00754017007810756,0.782352605744632
CR2,Complement receptor type 2,Blood and urine assays,X30300.High light scatter reticulocyte count,50815,0.0122418661428005,0.00342833823361249,0.00552232320492001,0.018961409080681,0.000356529218382427
CR2,Complement receptor type 2,Blood and urine assays,X30500.Microalbumin in urine,32067,0.0088136849859352,0.00586848148664608,-0.00268853872789112,0.0203159086997615,0.133169655787832
CR2,Complement receptor type 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51428,-0.0112588866707384,0.00327913843970696,-0.017685998012564,-0.00483177532891274,0.000596741411148863
CR2,Complement receptor type 2,Blood and urine assays,X30520.Potassium in urine,51366,-0.00968992627186772,0.00303612427264753,-0.0156407298462569,-0.00373912269747857,0.00141673227892917
CR2,Complement receptor type 2,Blood and urine assays,X30530.Sodium in urine,51369,-0.00997603661658039,0.00315813363142336,-0.0161659785341702,-0.0037860946989906,0.00158570143921524
CR2,Complement receptor type 2,Blood and urine assays,X30600.Albumin,48640,0.0394054510192472,0.00339169115856612,0.0327577363484576,0.0460531656900368,4.00969405282487e-31
CR2,Complement receptor type 2,Blood and urine assays,X30610.Alkaline phosphatase,50908,0.0638377504290765,0.00319904356688618,0.0575676250379795,0.0701078758201734,5.80207210505282e-88
CR2,Complement receptor type 2,Blood and urine assays,X30620.Alanine aminotransferase,50898,0.038609247110211,0.00339419260175566,0.0319566296107699,0.045261864609652,6.50846320516414e-30
CR2,Complement receptor type 2,Blood and urine assays,X30630.Apolipoprotein A,48503,-0.0642087335136504,0.00368260402564991,-0.0714266374039242,-0.0569908296233765,1.12758083200161e-67
CR2,Complement receptor type 2,Blood and urine assays,X30640.Apolipoprotein B,50744,-0.00671392170072972,0.00326979572515726,-0.0131227213220379,-0.000305122079421494,0.040051658116222
CR2,Complement receptor type 2,Blood and urine assays,X30650.Aspartate aminotransferase,50818,0.0296136779973694,0.00319384619993412,0.0233537394454985,0.0358736165492403,1.95737184879057e-20
CR2,Complement receptor type 2,Blood and urine assays,X30660.Direct bilirubin,46701,0.0153789495780194,0.00348713152835019,0.00854417178245301,0.0222137273735857,1.03746505432635e-05
CR2,Complement receptor type 2,Blood and urine assays,X30670.Urea,50899,0.0282589315392855,0.0033494438732679,0.0216940215476804,0.0348238415308906,3.41904915717124e-17
CR2,Complement receptor type 2,Blood and urine assays,X30680.Calcium,48634,0.0311988516028729,0.00330618384919698,0.0247187312584468,0.037678971947299,4.18157412137593e-21
CR2,Complement receptor type 2,Blood and urine assays,X30690.Cholesterol,50913,-0.0169270091974243,0.00335759198643434,-0.0235078894908356,-0.010346128904013,4.65086084784714e-07
CR2,Complement receptor type 2,Blood and urine assays,X30700.Creatinine,50903,0.0259756276290319,0.00404911769712346,0.0180393569426699,0.0339118983153939,1.43025790677611e-10
CR2,Complement receptor type 2,Blood and urine assays,X30710.C-reactive protein,50831,-0.0143237570754052,0.00349151315823715,-0.02116712286555,-0.00748039128526036,4.09998349529306e-05
CR2,Complement receptor type 2,Blood and urine assays,X30720.Cystatin C,50908,0.0713402628943863,0.00371492314964697,0.0640590135210782,0.0786215122676943,1.20595422546456e-81
CR2,Complement receptor type 2,Blood and urine assays,X30730.Gamma glutamyltransferase,50898,0.00927602321328168,0.00347491945508954,0.00246518108130618,0.0160868653452572,0.00760275123437548
CR2,Complement receptor type 2,Blood and urine assays,X30740.Glucose,48599,0.0123853711010663,0.00337033247168052,0.00577951945657245,0.0189912227455601,0.000238517990500742
CR2,Complement receptor type 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50664,0.03160492372148,0.0033852005558572,0.0249699306319999,0.0382399168109601,1.07338829140221e-20
CR2,Complement receptor type 2,Blood and urine assays,X30760.HDL cholesterol,48617,-0.066262676543038,0.00390234481791179,-0.0739112723861451,-0.0586140806999308,2.66186145539779e-64
CR2,Complement receptor type 2,Blood and urine assays,X30770.IGF-1,50786,0.0296857018286183,0.00329959353021737,0.0232184985093923,0.0361529051478443,2.47361749773098e-19
CR2,Complement receptor type 2,Blood and urine assays,X30780.LDL direct,50854,-0.00466216109998056,0.00332485275219663,-0.011178872494286,0.00185455029432483,0.160862310688091
CR2,Complement receptor type 2,Blood and urine assays,X30790.Lipoprotein A,45511,-0.00523028532139015,0.00350423604689977,-0.0120985879733137,0.00163801733053341,0.135566764327833
CR2,Complement receptor type 2,Blood and urine assays,X30810.Phosphate,48571,0.0209774818932823,0.00330976735965851,0.0144903378683516,0.0274646259182129,2.36702306375848e-10
CR2,Complement receptor type 2,Blood and urine assays,X30830.SHBG,48390,-0.0317776036214695,0.00383333320106804,-0.0392909366955628,-0.0242642705473761,1.19177352858983e-16
CR2,Complement receptor type 2,Blood and urine assays,X30840.Total bilirubin,50811,0.0203261579325983,0.00325553074021281,0.0139453176817812,0.0267069981834154,4.3405029288472e-10
CR2,Complement receptor type 2,Blood and urine assays,X30850.Testosterone,48743,-0.0288952344510321,0.00545930901659485,-0.039595480123558,-0.0181949887785062,1.21453045885399e-07
CR2,Complement receptor type 2,Blood and urine assays,X30860.Total protein,48619,0.0331724510076841,0.00335575610887545,0.0265951690342882,0.03974973298108,5.32168071415217e-23
CR2,Complement receptor type 2,Blood and urine assays,X30870.Triglycerides,50891,0.0140493972033611,0.00334323598701738,0.00749665466880705,0.0206021397379152,2.65023522605101e-05
CR2,Complement receptor type 2,Blood and urine assays,X30880.Urate,50877,0.0144017563427314,0.00402873553269781,0.00650543469864365,0.0222980779868191,0.00035116240692458
CR2,Complement receptor type 2,Blood and urine assays,X30890.Vitamin D,49802,-0.00490543034066825,0.00348371611953003,-0.0117335139349471,0.00192265325361062,0.159112622256483
CR2,Complement receptor type 2,Physical measures,X3137.Number of measurements made,49935,0.0154026556975326,0.0275266185874518,-0.038549516733873,0.0693548281289382,0.575787846543135
CR2,Complement receptor type 2,Physical measures,X3143.Ankle spacing width,39951,0.0210921579687821,0.00569746039564154,0.00992513559332472,0.0322591803442396,0.000214596970993773
CR2,Complement receptor type 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39950,-0.0060898787585313,0.00437755060531705,-0.0146698779449527,0.00249012042789012,0.164195771136537
CR2,Complement receptor type 2,Physical measures,X3146.Speed of sound through heel,39951,-0.00723860883998597,0.00425460800178301,-0.0155776405234807,0.00110042284350873,0.0888952137170793
CR2,Complement receptor type 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39951,-0.00720749923075399,0.00429619623699649,-0.0156280438552671,0.00121304539375913,0.0934355208738392
CR2,Complement receptor type 2,Physical measures,X3148.Heel bone mineral density (BMD),39941,-0.00746579105763942,0.00430243390808424,-0.0158985615174845,0.000966979402205678,0.0827159951230991
CR2,Complement receptor type 2,Health and medical history,X3526.Mother's age at death,35329,-0.00130247219279963,0.00580814287713555,-0.0126864322319853,0.0100814878463861,0.822567289591017
CR2,Complement receptor type 2,Health and medical history,X3581.Age at menopause (last menstrual period),30384,0.00551751261128538,0.00797301160598242,-0.0101095901364402,0.0211446153590109,0.48894709937952
CR2,Complement receptor type 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30351,0.0237752441499333,0.00716793652076441,0.00972608856923508,0.0378243997306316,0.000915263656508512
CR2,Complement receptor type 2,Physical measures,X4100.Ankle spacing width (left),32806,0.0242032856965768,0.00757207768323728,0.00936201343743171,0.0390445579557218,0.00139644421787188
CR2,Complement receptor type 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32805,-0.00229841385660594,0.0058454658259255,-0.0137555268754199,0.00915869916220804,0.69418408477402
CR2,Complement receptor type 2,Physical measures,X4103.Speed of sound through heel (left),32806,0.0011311924014882,0.00570462974524875,-0.0100498818991993,0.0123122667021758,0.842819750272458
CR2,Complement receptor type 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32806,-0.000221152953853491,0.00575742416650079,-0.011505704320195,0.0110633984124881,0.969360219918213
CR2,Complement receptor type 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),32798,0.0001359112943799,0.00577199295872501,-0.0111771949047211,0.0114490174934809,0.981214725963566
CR2,Complement receptor type 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32806,-0.000209362655376277,0.00575748619831571,-0.0114940356040751,0.0110753102933225,0.970993286652262
CR2,Complement receptor type 2,Physical measures,X4119.Ankle spacing width (right),32796,0.0231092547908197,0.00742273852773377,0.00856068727646147,0.0376578223051778,0.00185588602261225
CR2,Complement receptor type 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32796,-0.000650001264589745,0.00587980304887206,-0.012174415240379,0.0108744127111995,0.911977159687259
CR2,Complement receptor type 2,Physical measures,X4122.Speed of sound through heel (right),32796,0.00545277301207134,0.00572000302400215,-0.00575843291497287,0.0166639789391156,0.340473251523798
CR2,Complement receptor type 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32796,0.00326301124521667,0.00577866756205133,-0.00806317717640395,0.0145891996668373,0.572315826850912
CR2,Complement receptor type 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),32786,0.00285850538365019,0.00580103304971355,-0.00851151939378837,0.0142285301610888,0.622195718430985
CR2,Complement receptor type 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32796,0.00326724501403008,0.00577868497861389,-0.00805897754405314,0.0145934675721133,0.571818681690689
CR2,Complement receptor type 2,Physical measures,X4194.Pulse rate,33098,0.00593061618571518,0.00550922837325908,-0.00486747142587261,0.016728703797303,0.281737342218537
CR2,Complement receptor type 2,Physical measures,X4195.Pulse wave reflection index,33098,-0.00489262510469877,0.00539082460886467,-0.0154586413380735,0.00567339112867597,0.364121828231806
CR2,Complement receptor type 2,Physical measures,X4196.Pulse wave peak to peak time,33093,-0.00583204279467764,0.00580168746078029,-0.017203350217807,0.00553926462845174,0.31481141793696
CR2,Complement receptor type 2,Physical measures,X4198.Position of the pulse wave peak,33098,-0.00101404202758375,0.00554993525233614,-0.0118919151221626,0.0098638310669951,0.855027689787796
CR2,Complement receptor type 2,Physical measures,X4199.Position of pulse wave notch,33098,0.00319938445478767,0.00546313996310236,-0.00750836987289296,0.0139071387824683,0.558137776001582
CR2,Complement receptor type 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,33098,0.00238318546661775,0.00568977762364572,-0.00876877867572786,0.0135351496089634,0.675332658404226
CR2,Complement receptor type 2,Physical measures,X4269.Number of triplets attempted (left),32965,-0.0890568384260506,0.126952323685079,-0.337883392848806,0.159769715996705,0.483010055870316
CR2,Complement receptor type 2,Physical measures,X4270.Volume level set by participant (left),32878,-0.0524924566906572,0.0377468462841314,-0.126476275407555,0.0214913620262404,0.164367480558798
CR2,Complement receptor type 2,Physical measures,X4276.Number of triplets attempted (right),32971,-0.00646149366122655,0.123857385059843,-0.249221968378519,0.236298981056065,0.958395322228188
CR2,Complement receptor type 2,Physical measures,X4277.Volume level set by participant (right),32867,-0.0186852580884462,0.037788085485631,-0.092749905640283,0.0553793894633907,0.620982924179654
CR2,Complement receptor type 2,Cognitive function,X4288.Time to answer,33130,-0.000164891940735571,0.00626691178309944,-0.0124480390356105,0.0121182551541393,0.979009437144512
CR2,Complement receptor type 2,Cognitive function,X4290.Duration screen displayed,33130,0.0100116296933165,0.00555896033710397,-0.000883932567407241,0.0209071919540403,0.0717370083633919
CR2,Complement receptor type 2,Physical measures,X46.Hand grip strength (left),52134,-0.0143600758472363,0.00437215691856493,-0.0229295034076235,-0.00579064828684899,0.00102310364082571
CR2,Complement receptor type 2,Physical measures,X47.Hand grip strength (right),52114,-0.0119051631386395,0.00433493942849908,-0.0204016444184977,-0.00340868185878134,0.00603047206495044
CR2,Complement receptor type 2,Physical measures,X48.Waist circumference,52191,0.012587697642712,0.0068541197100288,-0.000846376988944457,0.0260217722743684,0.0662919106825832
CR2,Complement receptor type 2,Health and medical history,X4803.Tinnitus,32920,0.0308900036202299,0.0463951788368611,-0.0600445469000179,0.121824554140478,0.505554612013438
CR2,Complement receptor type 2,Working and living environment,X4825.Noisy workplace,33057,-0.0383143274645147,0.0516876451255839,-0.139622111910659,0.0629934569816297,0.458550709995467
CR2,Complement receptor type 2,Working and living environment,X4836.Loud music exposure frequency,32992,-0.0313562984951037,0.055773515841215,-0.140672389543885,0.0779597925536777,0.573988337027008
CR2,Complement receptor type 2,Physical measures,X49.Hip circumference,52187,0.00561453600206291,0.00541312782691229,-0.00499519453868518,0.016224266542811,0.299648084095671
CR2,Complement receptor type 2,Physical measures,X50.Standing height,52163,0.0153156558800473,0.00429213194128308,0.00690307727513247,0.0237282344849621,0.000359885468309702
CR2,Complement receptor type 2,Health and medical history,X5057.Number of older siblings,32266,-0.0451555606785961,0.0395578038690349,-0.122688856261905,0.0323777349047124,0.253690988607826
CR2,Complement receptor type 2,Physical measures,X51.Seated height,52025,0.0110576129974722,0.00398127663585053,0.00325431079120512,0.0188609152037392,0.00548312782767506
CR2,Complement receptor type 2,Eye measures,X5181.Ever had eye surgery,30110,0.110739980270117,0.100002685766445,-0.0852652838321162,0.306745244372349,0.268176593942898
CR2,Complement receptor type 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),30095,0.0154141867052332,0.00679971920469663,0.00208673706402776,0.0287416363464386,0.0234313064427756
CR2,Complement receptor type 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),30094,0.00995812622219213,0.00674594310503973,-0.00326392226368574,0.02318017470807,0.13995006578532
CR2,Complement receptor type 2,Eye measures,X5190.Duration at which refractometer first shown (right),30039,0.0124382587965943,0.00666393788057413,-0.000623059449331005,0.0254995770425196,0.0620183823258467
CR2,Complement receptor type 2,Eye measures,X5193.Duration at which refractometer first shown (left),30038,0.00564893025473236,0.0066875395285809,-0.0074586472212862,0.0187565077307509,0.398313939900716
CR2,Complement receptor type 2,Eye measures,"X5199.logMAR, initial (right)",30072,-0.0614084954702186,0.0472841920216658,-0.154085511832684,0.0312685208922463,0.19409137664765
CR2,Complement receptor type 2,Eye measures,X5200.Final number of letters displayed (right),30072,0.464405957110452,0.364724575149392,-0.250454210182357,1.17926612440326,0.202957170767132
CR2,Complement receptor type 2,Eye measures,"X5201.logMAR, final (right)",30017,-0.0105807404819685,0.00646421433354999,-0.0232506005757264,0.00208911961178951,0.101719671689667
CR2,Complement receptor type 2,Eye measures,X5202.Number of rounds to result (right),30072,-0.0133643348318483,0.0451522337679638,-0.101862713017057,0.0751340433533607,0.767252278003735
CR2,Complement receptor type 2,Eye measures,"X5206.logMAR, initial (left)",30069,0.0268655513981617,0.0468417947855118,-0.0649443663814414,0.118675469177765,0.566301222849526
CR2,Complement receptor type 2,Eye measures,X5207.Final number of letters displayed (left),30069,0.0379889127509213,0.311787515309022,-0.573114617254762,0.649092442756605,0.903027845060473
CR2,Complement receptor type 2,Eye measures,"X5208.logMAR, final (left)",30018,0.00179971417054175,0.00645670101950464,-0.0108554198276873,0.0144548481687708,0.780456892792359
CR2,Complement receptor type 2,Eye measures,X5209.Number of rounds to result (left),30065,-0.00818646507574045,0.0450794478801974,-0.0965421829209273,0.0801692527694464,0.855901940953948
CR2,Complement receptor type 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29826,0.00995436054560258,0.00671007344084075,-0.00319738339844528,0.0231061044896505,0.137995762216782
CR2,Complement receptor type 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29826,0.0111815626156696,0.00657959988944804,-0.00171445316764857,0.0240775783989878,0.0892905196883487
CR2,Complement receptor type 2,Eye measures,X5256.Corneal hysteresis (right),29826,0.000595404880367343,0.00675897945095613,-0.0126521948435067,0.0138430046042414,0.929807350622074
CR2,Complement receptor type 2,Eye measures,X5257.Corneal resistance factor (right),29826,0.00650293674012985,0.00662674568814828,-0.00648548480864077,0.0194913582889005,0.326476342456892
CR2,Complement receptor type 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29807,0.0151619619304686,0.00678452547791799,0.00186429199374935,0.0284596318671878,0.0254684029945806
CR2,Complement receptor type 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29807,0.0177035245551127,0.00661957099998379,0.00472916539514448,0.030677883715081,0.00750629920927612
CR2,Complement receptor type 2,Eye measures,X5264.Corneal hysteresis (left),29807,0.00113237973877487,0.00672782375562349,-0.0120541548222472,0.0143189142997969,0.866342824764073
CR2,Complement receptor type 2,Eye measures,X5265.Corneal resistance factor (left),29807,0.0099949610567701,0.00659222527779343,-0.00292580048770502,0.0229157226012452,0.129528491026291
CR2,Complement receptor type 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29922,0.0125518150332338,0.187990138679946,-0.355908856779461,0.381012486845929,0.946768222245962
CR2,Complement receptor type 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52093,0.00693087693977353,0.0186814752125386,-0.029684814476802,0.0435465683563491,0.710638336406099
CR2,Complement receptor type 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52093,0.0258052649161739,0.0209685843677021,-0.0152931604445223,0.0669036902768701,0.218459113739188
CR2,Complement receptor type 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52093,0.0245189580917705,0.0491440899011794,-0.0718034581145411,0.120841374298082,0.617839792101033
CR2,Complement receptor type 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52093,0.0037437958990769,0.00862748769449415,-0.0131660799821316,0.0206536717802854,0.664336683778005
CR2,Complement receptor type 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52093,-0.00488430986356997,0.00773622012208823,-0.0200473013028629,0.010278681575723,0.527812816350649
CR2,Complement receptor type 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37907,-0.00114481271590079,0.00884454288127914,-0.0184801167632079,0.0161904913314063,0.897013580549672
CR2,Complement receptor type 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37907,-0.0306009918650927,0.0314377779364443,-0.0922190366205236,0.0310170528903381,0.330379852342516
CR2,Complement receptor type 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37907,-0.0493602139866429,0.0150525723240993,-0.0788632557418776,-0.0198571722314082,0.00104359507154449
CR2,Complement receptor type 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37907,0.00778601093091191,0.00954755599513817,-0.0109271988195589,0.0264992206813827,0.414801248992894
CR2,Complement receptor type 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52174,-0.021531379504298,0.017495144690275,-0.0558218630972371,0.012759104088641,0.218443067637286
CR2,Complement receptor type 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52174,-0.021531379504298,0.017495144690275,-0.0558218630972371,0.012759104088641,0.218443067637286
CR2,Complement receptor type 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52174,-0.0266062360415403,0.0128350320012973,-0.0517628987640829,-0.00144957331899765,0.0381869983137353
CR2,Complement receptor type 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52174,0.0228784301162313,0.0200698044690698,-0.0164583866431456,0.0622152468756081,0.254319754192453
CR2,Complement receptor type 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52174,0.0689930884586665,0.048351929569166,-0.0257766934968989,0.163762870414232,0.153621416282072
CR2,Complement receptor type 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52174,0.0171796693479211,0.0340968618976263,-0.0496501799714265,0.0840095186672688,0.614371420308553
CR2,Complement receptor type 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52174,-0.0138075073528045,0.0516804353932935,-0.11510116072366,0.0874861460180509,0.789339542441494
CR2,Complement receptor type 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52092,-0.0129094253338024,0.00981568945438194,-0.0321481766643909,0.00632932599678624,0.188459176650884
CR2,Complement receptor type 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52092,0.0229416430056427,0.0169484389348252,-0.0102772973066148,0.0561605833179002,0.175870417480232
CR2,Complement receptor type 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52092,0.00895153764264192,0.0082442257845255,-0.00720714489502806,0.0251102201803119,0.277579050090648
CR2,Complement receptor type 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52092,0.00417738279445856,0.0155678015814234,-0.0263355083051313,0.0346902738940484,0.788443588499017
CR2,Complement receptor type 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52092,-0.00436059046951989,0.013471378375085,-0.0307644920846865,0.0220433111456468,0.74617289175079
CR2,Complement receptor type 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52092,-0.00144484493640802,0.0109854759801893,-0.022976377857579,0.020086687984763,0.895362373533803
CR2,Complement receptor type 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,30104,0.0219767027419046,0.0296548154330305,-0.0361467355068351,0.0801001409906444,0.45867051208333
CR2,Complement receptor type 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,30104,-0.00463052524471431,0.0259009013825298,-0.0553962919544728,0.0461352414650442,0.858117399348243
CR2,Complement receptor type 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,30104,0.0219164896741225,0.0322162227180708,-0.0412273068532963,0.0850602862015414,0.496343807690944
CR2,Complement receptor type 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,30104,0.0296348541745119,0.026551232944182,-0.0224055623960847,0.0816752707451086,0.264405790943296
CR2,Complement receptor type 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52045,0.0134783492912833,0.0273256845640354,-0.040079992454226,0.0670366910367927,0.621840949313768
CR2,Complement receptor type 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52045,0.0110073756003942,0.0394699497078774,-0.0663537258270454,0.0883684770278339,0.780339040876268
CR2,Complement receptor type 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52045,0.0801254742384697,0.0819412210899741,-0.0804793190978794,0.240730267574819,0.328161430590659
CR2,Complement receptor type 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52045,-0.0848178444894912,0.0702869560322307,-0.222580278312663,0.0529445893336809,0.227543715385637
CR2,Complement receptor type 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52045,0.0285749959257742,0.0253182691085447,-0.0210488115269733,0.0781988033785218,0.259062925060748
CR2,Complement receptor type 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52045,-0.0308720465901189,0.032231800919521,-0.0940463763923801,0.0323022832121422,0.338165142863879
CR2,Complement receptor type 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52045,-0.0217010649234694,0.0132333976562043,-0.0476385243296298,0.00423639448269103,0.101043153398514
CR2,Complement receptor type 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33606,0.0250807956636379,0.0247010499492337,-0.0233332622368601,0.073494853564136,0.309952946406412
CR2,Complement receptor type 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33606,-0.0147933651681263,0.0280624720427057,-0.0697958103718295,0.040209080035577,0.598095659954708
CR2,Complement receptor type 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33606,0.0356053517121143,0.0358487299203613,-0.0346581589317938,0.105868862356022,0.320631812823374
CR2,Complement receptor type 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33606,-0.000936479040805457,0.010703168638332,-0.0219146895719363,0.0200417314903253,0.930279463527257
CR2,Complement receptor type 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35780,0.0312009317731805,0.0120777266991555,0.00752858744283581,0.0548732761035253,0.00979654538896846
CR2,Complement receptor type 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35780,-0.0379241280765207,0.00975029993389285,-0.0570347159469507,-0.0188135402060907,0.000100982201137841
CR2,Complement receptor type 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35780,0.00120229818851224,0.00965879378250502,-0.0177289376251976,0.0201335340022221,0.900939666821223
CR2,Complement receptor type 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35781,-0.00325527996851917,0.0234136604005194,-0.0491460543535371,0.0426354944164988,0.889426132983171
CR2,Complement receptor type 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35781,0.00311432514744525,0.0153952994972633,-0.0270604618671908,0.0332891121620813,0.839692960831274
CR2,Complement receptor type 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35781,-0.0145540755807568,0.0192678798664668,-0.0523191201190317,0.0232109689575181,0.450051359714206
CR2,Complement receptor type 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52092,-0.007981235391496,0.0228724151712413,-0.052811169127129,0.036848698344137,0.727132530900964
CR2,Complement receptor type 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52092,-0.018750618184773,0.0149715531484926,-0.0480948623558185,0.0105936259862725,0.210428560355015
CR2,Complement receptor type 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52092,0.0550237550257853,0.0454077683549216,-0.0339754709498611,0.144022981001432,0.225610715373304
CR2,Complement receptor type 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52092,-0.0128473380066936,0.0168600503239973,-0.0458930366417284,0.0201983606283412,0.446067089776043
CR2,Complement receptor type 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52092,0.00401426635024867,0.018556089758207,-0.0323556695758371,0.0403842022763344,0.828730935911025
CR2,Complement receptor type 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52092,-0.0215965178073268,0.0204828869983953,-0.0617429763241816,0.0185499407095279,0.291723105644357
CR2,Complement receptor type 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52092,0.00271972451872853,0.00659886440968252,-0.0102140497242492,0.0156534987617063,0.680232328331967
CR2,Complement receptor type 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28102,0.0460853026880914,0.0226720936733231,0.00164799908837823,0.0905226062878046,0.0421461677748334
CR2,Complement receptor type 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28102,0.0608365882479343,0.0288106749650729,0.00436766531639133,0.117305511179477,0.0347791985437692
CR2,Complement receptor type 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28102,-0.0574249040327685,0.021095756704098,-0.0987725871728006,-0.0160772208927364,0.00651322424095675
CR2,Complement receptor type 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28102,0.0368424793113459,0.0174643821458361,0.00261229030550711,0.0710726683171846,0.0349531357193599
CR2,Complement receptor type 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52227,0.00465924498473432,0.00707564624514911,-0.00920902165575792,0.0185275116252266,0.510228420831819
CR2,Complement receptor type 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52227,-0.011238891065217,0.0206773382043445,-0.0517664739457322,0.0292886918152982,0.586764637542129
CR2,Complement receptor type 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52227,0.0122865813881115,0.00713942397502066,-0.001706689602929,0.026279852379152,0.0852710634403788
CR2,Complement receptor type 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52227,0.000395322088547742,0.00694185228003621,-0.0132107083803232,0.0140013525574187,0.954587307558441
CR2,Complement receptor type 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52227,0.0069847208079847,0.0100480821277306,-0.0127095201623672,0.0266789617783366,0.48697968666066
CR2,Complement receptor type 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52227,0.0113492049930719,0.0103345356906923,-0.0089064849606851,0.0316048949468288,0.272134179976439
CR2,Complement receptor type 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52227,0.000392668118570813,0.00764889097036172,-0.0145991581833382,0.0153844944204798,0.959057658922752
CR2,Complement receptor type 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52227,0.0685256071526003,0.0216701492298475,0.0260521146620992,0.110999099643101,0.00156740384168285
CR2,Complement receptor type 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43031,-0.0157132193898835,0.00753964777415612,-0.0304909290272295,-0.000935509752537537,0.0371662161961928
CR2,Complement receptor type 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43031,-0.0542909941476027,0.00791203457284041,-0.0697985819103699,-0.0387834063848355,7.00624654564784e-12
CR2,Complement receptor type 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43031,0.0582305875009709,0.00947701075497336,0.0396556464212231,0.0768055285807187,8.18475035099156e-10
CR2,Complement receptor type 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43032,0.0159068252695963,0.0130321245262651,-0.00963613880188322,0.0414497893410758,0.222257922573478
CR2,Complement receptor type 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43032,0.0166696992857909,0.0083511821709564,0.000301382230716303,0.0330380163408654,0.0459384023086357
CR2,Complement receptor type 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51987,-0.00335802400723611,0.0078312311581391,-0.0187072370771887,0.0119911890627165,0.668072798172258
CR2,Complement receptor type 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51987,0.011516266701291,0.00614163709350494,-0.000521342001978661,0.0235538754045607,0.0607874615336336
CR2,Complement receptor type 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51987,-0.0024191237337409,0.00733461383634792,-0.0167949668529828,0.011956719385501,0.741536226034823
CR2,Complement receptor type 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51987,-0.0116267455820161,0.0114236377743474,-0.0340170756197369,0.0107635844557048,0.308791459054983
CR2,Complement receptor type 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52003,-0.0238671979703973,0.00673912737488933,-0.0370758876251804,-0.0106585083156142,0.000398372138321546
CR2,Complement receptor type 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52003,-0.0387808461892212,0.00923898857236637,-0.0568892637910593,-0.0206724285873831,2.70680878596706e-05
CR2,Complement receptor type 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52092,-0.00064148112788837,0.0071218673111996,-0.0146003410578396,0.0133173788020628,0.928230605515423
CR2,Complement receptor type 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52092,-0.0100650770395615,0.00875983738045787,-0.0272343583052589,0.00710420422613597,0.250564590387549
CR2,Complement receptor type 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52092,-0.0147846745246572,0.0131622685451734,-0.040582720873197,0.0110133718238825,0.261335839690632
CR2,Complement receptor type 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52092,-0.00632489717152318,0.0153276825896163,-0.0363671550471712,0.0237173607041248,0.679869592766196
CR2,Complement receptor type 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52092,0.000583000414353067,0.0150561016282927,-0.0289269587771005,0.0300929596058067,0.969112410302478
CR2,Complement receptor type 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52092,-0.00101429928009879,0.021630432042651,-0.0434099460836947,0.0413813475234971,0.962599449361361
CR2,Complement receptor type 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39951,-0.00720687345838627,0.00429621955593309,-0.0156274637880151,0.00121371687124259,0.0934657558830519
CR2,Complement receptor type 2,Physical activities,X864.Number of days or week walked 10+ minutes,51702,-0.0566491100852654,0.0214365241816695,-0.0986646974813376,-0.0146335226891932,0.00823074215952844
CR2,Complement receptor type 2,Physical activities,X874.Duration of walks,48057,0.00190727839634687,0.00318950077114019,-0.0043441431150879,0.00815869990778164,0.549854538951098
CR2,Complement receptor type 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50971,-0.0893422332130886,0.0209795582454365,-0.130462167374144,-0.0482222990520331,2.06461382224103e-05
CR2,Complement receptor type 2,Physical activities,X894.Duration of moderate activity,44847,-0.027180832279301,0.0253672571570628,-0.076900656307144,0.0225389917485421,0.283960248245301
CR2,Complement receptor type 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,30321,-0.0131142730711883,0.00647850425378023,-0.0258121414085976,-0.000416404733779088,0.042982945944424
CR2,Complement receptor type 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50976,-0.137925420429131,0.0214947867900702,-0.180055202537669,-0.0957956383205937,1.41565928920549e-10
CR2,Complement receptor type 2,Physical activities,X914.Duration of vigorous activity,39874,-0.00954575618573356,0.00404817340491086,-0.0174801760593588,-0.00161133631210828,0.0183836498260288
